1. Schlesinger T, Kircik L, Lebwohl M, Patel VA, Berman B, Bhatia N, Rigel D, Armstrong A, Del Rosso J, Narayanan S, Koscielny V. Patient- and Clinician-Reported Outcomes for Tirbanibulin in Actinic Keratosis in Clinical Practice Across the United States (PROAK). J Drugs Dermatol. 2024;23(5):338-346.
2. Miller DM, Brownell I, Tchekmedyian V, Patel VA, Kaufman HL, Emerick KS. Perspectives on Medical Aid in Dying: A Multifaceted Ethical Discussion. Journal of Cutaneous Oncology 2, (2024).
3. Ching L, Strong J, Lee T, Kaufman HL, Emerick KS, Kim EY, Patel VA, Brownell I, Singh K, Neel VA, Miller DM. A Closer Look: Evaluating Mohs Surgery’s Role in the Treatment of Invasive Melanoma of the Head and Neck. Journal of Cutaneous Oncology 2, (2024).
4.Desai S, Sadur A, Farah M, Nasseri M, Friedman A. The Potential Impact of Off- Label Medication Use on Patient Access: A Cross-Sectional Survey of Minoxidil Availability.J Drugs Dermatol. 2024. 1;23(1):1360-1361.
5.Desai S, Sanfilippo E, Friedman A. Oral Minoxidil Media Coverage: The Impact on Patient Perceptions and Practitioner Approaches to Androgenetic Alopecia J Drugs Dermatol. 2024. 1;23(1):1364-1366
6.McCormick E, Nussbaum D, Friedman A, Pham H, Meckfessel MH, Emesiani C. Evaluation of a Moisturizing Cream with 20% Urea for Keratosis Pilaris. J Drugs Dermatol. 2024.1;23(1):1274-1277.
7.Whiting C, Abdel Azim S, Friedman A. The Skin Microbiome and its Significance for Dermatologists. Am J Clin Dermatol. 2024 Jan 22. doi: 10.1007/s40257-023-00842- z. Online ahead of print.
8.Millan SH, Sellyn GE, Friedman AJ. Perceptions, Utilization, and Cost Assessment of Sebaceous Hyperplasia Treatment Modalities: A Pilot Survey. J Drugs Dermatol. 2024 Feb 1;23(2):29-37.
9.Whiting C, Azim SA, Friedman A. What's Old Is New: An Emerging Focus on DermatoporosisJ Drugs Dermatol. 2024 Feb 1;23(2):113-114
10.McCormick ET, Friedman A. Sensitive Skin: A Survey of Dermatology Resident Physicians' Perspectives and Educational Exposures J Drugs Dermatol. 2024 Feb 1;23(2):85-89.
11.Wei C, Mustafa A, Strange J, Grovu R, Strange T, Friedman AJ, Bradu S, Garg A, El-Sayegh SE. Association of chronic kidney disease with hidradenitis suppurativa: A retrospective study. JAAD Int. 2024 Jan 4;15:36-37.
12.Abdel Azim S, Whiting C, Friedman AJ. Applications of nitric oxide-releasing nanomaterials in dermatology: Skin infections and wound healing/ Nitric Oxide. 2024 Mar 6:S1089-8603(24)00030-2. doi: 10.1016/j.niox.2024.03.001. Online ahead of print.
13. Azim SA, Whiting C, Friedman A. Highlighting the Link Between Lichen Planus Pigmentosus and Frontal Fibrosing AlopeciaJ Drugs Dermatol. 2024 Mar 1;23(3):196-198.
14.Sanfilippo E, Friedman A. Survey of Dermatology Practitioners' Opinions and Prescribing Habits of Oral Minoxidil for the Treatment of Androgenetic Alopecia. J Drugs Dermatol. 2024 Mar 1;23(3):136-140.
2023
1. Gross ND, Miller DM...Patel VA, et al. Neoadjuvant cemiplimab and surgery for stage II–IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study. Lancet Oncology. 2023 October 21.
2. Shatanofy ME, Thakkar P, Patel VA, Joshi A, Goodman J, Siegel R, Haroun F, Ojong-Ntui M, Goyal S, Bauman J, Rao YJ. Intensified Adjuvant Treatment for High-Risk Resected CutaneousAngiosarcoma of the Head and Neck. Otolaryngol Head Neck Surg. 2023 Jul 19.
3. Schlesinger, T., Kircik, L., Del Rosso, J., Rigel, D., Lebwohl, M., Berman, B., Armstrong, A., Bhatia, N., Patel, VA., Narayanan, S., Koscielny, V., and Kasujee, I. Clinician- and Patient-Reported Outcomes with Tirbanibulin 1% Treatment for Actinic Keratosis in Routine Clinical Practice Across the U.S. (PROAK Study). SKIN The Journal of Cutaneous Medicine, 2023 7(3), 771–787.
4. Vilasi S, Miller DM, Kaufman HL, Emerick KS, Shalhout SZ, Kim EY, Patel VA, Garmen K, Gupta S, and Brownell I. 2023. “Perioperative Immunotherapy for High-Risk Resectable Melanoma - A New Standard?” Journal of Cutaneous Oncology 1 (1).
5. Russomanno K, Azim SA, Patel VA. Immunomodulators for Non-Melanoma Skin Cancers: Updated Perspectives. Clinical, Cosmetic, and Investigational Dermatology 2023 Apr 18;16:1025- 1045.
6. Miller DM, Emerick KS, Patel VA, Cohen S, Brownell I, Lawrence DP. 2023. “Lacking Overall IMspiration for Triplet Therapy in Melanoma? A Review of the Interim Analysis of IMspire150.” Journal of Cutaneous Oncology 1
7. Kim EY, Shalhout SS, Kaufman HL, Emerick KS, Patel VA, Garmen K, Brownell I, and Miller DM. Tumor-Infiltrating Lymphocyte Therapy for Advanced Melanoma: Ready for Prime Time?” Journal of Cutaneous Oncology 1 (1). 2023
8. Samynathan A, Silverberg JI. Navigating the Atopic Dermatitis Toolbox: Challenging Scenarios and Shared Decision Making. Annals of Allergy, Asthma and Immunology. 2023. In Press.
9. Silverberg JI, Boguniewicz M, Quintana FJ, Clark RA, Gross L, Hirano I, Tallman AM, Brown PM, Fredericks D, Rubenstein DS, McHale KA. Tapinarof Validates the Aryl Hydrocarbon Receptor as a Therapeutic Target: A Clinical Review. Journal of Allergy and Clinical Immunology. 2023. In Press
10. Silverberg JI, Kirsner RS, Margolis DJ, Tharp M, Myers DE, Annis K, Graham D, Zang C, Vlahos BL, Sanders P. Efficacy and safety of crisaborole ointment, 2%, in participants aged ≥45 years with stasis dermatitis: Results from a fully decentralized, randomized, proof-of- concept phase 2a study. Journal of the American Academy of Dermatology. 2023. In Press.
11. Silverberg JI, Smith-Norowitz TA, Kohlhoff S, Joks R. Phosphorylated p38 MAP Kinase Expression by Leukocytes is Increased in Allergic Humans and Associated with IgE Responses. Scandinavian Journal of Immunology. 2023. In Press.
12. Eichenfield LF, Silverberg JI, Hebert AA, Boguniewicz M. Targeting the Aryl Hydrocarbon Receptor to Address the Challenges of Atopic Dermatitis. Journal of Drugs in Dermatology. 2023. In Press.
13. Ju T, Andrade LF, Lalama MJ, Soares GB, Maskan N, Silverberg JI. Psychiatric medication for the treatment of atopic dermatitis: A sub-analysis of a systematic review. Journal of the European Academy of Dermatology and Venereology. 2023. In Press.
14. Silverberg JI, Strober B, Feinstein B, Xu J, Guttman-Yassky E, Simpson EL, Li P, Longphre M, Song J, Guo J, Yun J, Williams B, Pan W, Ho S, Collazo R, Wei Z. Efficacy and safety of rademikibart (CBP-201), a next-generation monoclonal antibody targeting IL- 4Ra, in adults with moderate-to-severe atopic dermatitis: a phase 2 randomized trial (CBP- 201-WW001). Journal of the American Academy of Allergy, Asthma and Immunology. 2023. In Press.
15. Thyssen JP, Bewley A, Ständer S, Castro C, Misery L, Kim BS, Biswas P, Chanh G, Myers DE, Watkins M, Alderfer J, Güler E, Silverberg JI. Abrocitinib Provides Rapid and Sustained Improvement in Skin Pain and Is Associated With Improved Quality of Life Outcomes in Adult and Adolescent Patients With Moderate-to-Severe Atopic Dermatitis. Dermatology. 2023. In Press.
16. Veverka K, Thng STG, Silverberg JI, Armstrong AW, Menezes J, Kaoukhov A, Blauvelt A. Safety and Efficacy of Eblasakimab, an IL-13Ra1 Monoclonal Antibody, in Adults with Moderate-to-Severe Atopic Dermatitis: A Randomized Proof-of-Concept Study. Journal of the American Academy of Dermatology. 2023. In Press.
17. Weidinger S, Simpson EL, Silverberg JI, Barbarot S, Eckert L, Mina-Osorio P, Rossi AB, Brignoli L, Mnif T, Guillemin I, Fenton MC, Delevry D, Chuang C, Pellan M, Gadkari A. Burden of Atopic Dermatitis in Pediatric Patients: An International Cross-sectional Study. British Journal of Dermatology. 2023. In Press.
18. Simpson EL, Silverberg JI, Worm M, Honari G, Masuda K, Sygula E, Schuttelaar MLA, Mortensen E, Laws E, Akinlade B, Patel N, Maloney J, Paleczny H, Delevry D, Xiao J, Dubost-Brama A, Bansal A. Dupilumab treatment improves signs, symptoms, quality of lifeand work productivity in patients with atopic hand and foot dermatitis: results from a phase 3, randomized, double-blind, placebo-controlled trial. Journal of the American Academy of Dermatology. 2023. In Press.
19. Davis DMR, Drucker AM, Alikhan A, Bercovitch L, Cohen DE, Darr JM, Eichenfield LF, Frazer-Green L, Paller AS, Schwarzenberger K, Silverberg JI, Singh AM, Wu PA, Sidbury R. Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies. Journal of the American Academy of Dermatology. 2023. In Press.
20. Davis DMR, Drucker AM, Alikhan A, Bercovitch L, Cohen DE, Darr JM, Eichenfield LF, Frazer-Green L, Paller AS, Schwarzenberger K, Silverberg JI, Singh AM, Wu PA, Sidbury R. Executive Summary: Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies. Journal of the American Academy of Dermatology. 2023. In Press.
21. Bissonnette R, Simpson E, Eichenfield LF, Guttman-Yassky E, Silverberg JI, Beck LA, Mija L, Thyssen JP, Bieber T, Kabashima K, Siegfried E, Stingl G, van de Kerkhof P, Yosipovitch G, Paul C, Paller AS. The vIGA-AD scale for atopic dermatitis: uptake in the past five years and position of the International Eczema Council. Journal of the European Academy of Dermatology and Venereology. 2023. In Press.
22. Alexis AF, Silverberg JI, Rice ZP, Armstrong AW, Desai SR, Fonacier L, Kabashima K, Biswas P, Cella RR, Chan GL, Levenberg M. Abrocitinib efficacy and safety in moderate-to- severe atopic dermatitis by race, ethnicity, and Fitzpatrick skin type. Annals of Allergy, Asthma and Immunology. 2023. In Press.
23. Warren RB, Langley RG, Gordon KE, Silverberg JI, Eyerich K, Sommer MOA, Felding J, Blauvelt A. Next generation PDE4 inhibitors selectivity targeting PDE4B/D subtypes. Dermatology and Therapy. 2023. In Press.
24. Silverberg JI, Ho S, Collazo R. A Mini Review of the Impact of Baseline Disease Severity on Clinical Outcomes: Should We Compare Atopic Dermatitis Clinical Trials? Dermatology and Therapy. 2023. In Press.
25. Silverberg JI, Leshem YA, Calimlim BM, McDonald J, Litcher-Kelly L. Psychometric evaluation of the Worst Pruritus Numerical Rating Scale (NRS), Atopic Dermatitis Symptom Scale (ADerm-SS), and Atopic Dermatitis Impact Scale (ADerm-IS). Current Medical Research and Opinion. 2023. In Press.
26. Silverberg JI / Patel N, Warshaw EM, DeKoven JG, Belsito DV, Atwater AR, Taylor JS, Sasseville D, Reeder MJ, Houle MC, DeLeo VA, Maibach HI, Fowler JF, Zug KA, Pratt MD, Yu J, Mowad CM, Botto NC, Adler BL. Patch testing with nickel, cobalt, and chromium in patients with suspected allergic contact dermatitis. Dermatitis. 2023. In Press.
27. Silverberg JI, Pierce E, Feely M, Atwater AR, Schrader A, Jones EA, Dave SE, Simpson EL. Disease Burden Among Patients With Atopic Dermatitis Treated With Systemic Therapy for 4–12 Months: Results From the CorEvitas Atopic Dermatitis Registry. Journal of Dermatological Treatment. 2023. In Press.
28. Renert-Yuval Y, Del Duca E, Arents B, Bissonnette R, Drucker AM, Flohr C, Guttman- Yassky E, Hijnen D, Kabashima K, Leshem YA, Paller AS, Silverberg JI, Simpson EL, Spuls P, Vestergaard C, Wollenberg A, Irvine AD, Thyssen JP. Treat-to-target in dermatology: A scoping review and International Eczema Council survey on the approach in atopic dermatitis. Journal of the European Academy of Dermatology and Venereology. 2023. In Press.
29. Eyerich K, Gooderham MJ, Silvestre JF, Shumack SP, Mendes-Bastos P, Aoki V, Ortoncelli M, Silverberg JI, Teixeira HD, Chen SH, Calimlim BM, Takemoto S, Sancho C, Fritz B, Irvine AD. Real-world clinical, psychosocial and economic burden of atopic dermatitis: Results from a multicountry study. Journal of the European Academy of Dermatology andVenereology. 2023. In Press.
30. Chatrath S, LeBovidge J, Jack C, Abuabara K, Schneider LC, Capozza K, Kelley K, Silverberg JI. Mental Health Interventions for Atopic Dermatitis: Knowledge Gaps, Pilot Programs, and Future Directions. Clinical and Experimental Dermatology. 2023. In Press.
31. Sanfilipo E, Iyer S, Patel N, Silverberg JI. Assessment of racial and ethnic differences of atopic dermatitis severity and treatment patterns in a diverse outpatient cohort in the United States: A retrospective observational study. Archives of Dermatological Research. 2023. In Press.
32. Simpson EL, Blauvelt A, Silverberg JI, Cork MJ, Katoh N, Mark T, Schneider SKR, Wollenberg A. Tralokinumab Provides Clinically Meaningful Responses at Week 16 in Adults with Moderate-to-Severe Atopic Dermatitis Who Do Not Achieve IGA 0/1. American Journal of Clinical Dermatology. 2023. In Press. https://doi.org/10.1007/s40257-023-00817-0
33. Penton H, Jayade S, Selveindran S, Heisen M, Piketty C, Ulianov L, Jabbar-Lopez ZK, Silverberg JI, Puelles J. Assessing Response in Atopic Dermatitis: A Systematic Review of the Psychometric Performance of Measures Used in HTAs and Clinical Trials. Dermatology and Therapy. 2023. In Press.
34. Eyerich K, Gooderham MJ, Silvestre JF, Shumack SP, Mendes-Bastos P, Aoki V, Ortoncelli M, Silverberg JI, Teixeira HD, Chen SH, Calimlim BM, Takemoto S, Sancho C, Fritz B, Irvine AD. Real-World Clinical, Psychosocial, and Economic Burden of Atopic Dermatitis: Results From a Multicountry Study. Journal of the European Academy of Dermatology and Venereology. 2023. In Press.
35. Chu DK, Chu AWL, Rayner DG, Guyatt GH, Yepes-Nuñez JJ, Gomez-Escobar L, Pérez- Herrera LC, Díaz Martinez JP, Brignardello-Petersen R, Sadeghirad B, Wong MW, Ceccacci R, Zhao IX, Basmaji J, MacDonald M, Chu X, Islam N, Gao Y, Izcovich A, Asiniwasis RN, Boguniewicz M, De Benedetto A, Capozza K, Chen L, Ellison K, Frazier WT, Greenhawt M, Huynh J, LeBovidge J, Lio PA, Martin SA, O’Brien M, Ong PY, Silverberg JI, Spergel JM, Smith Begolka W, Wang J, Wheeler KE, Gardner DG, Schneider L. Topical treatments for atopic dermatitis (eczema): systematic review and network meta-analysis of randomized trials. Journal of Allergy and Clinical Immunology. In Press.
36. Renert-Yuval Y, Del Duca E, Paller AS, Wollenberg A, Vestergaard C, Flohr C, Hijnen D, Guttmann-Yassky E, Simpson E, Silverberg JI, Kabashima K, Spuls P, Bissonnette R, Leshem Y, Irvine AD, Thyssen JP. Treat-To-Target in Dermatology: A Scoping Review and International Eczema Council Survey on the Approach in Atopic-Dermatitis. Journal of the European Academy of Dermatology and Venereology. 2023. In Press.
37. Silverberg JI, Hong HC, Calimlim BM, Lee WJ, Teixeira HD, Collins EB, Crowell MM, Johnson SJ, Armstrong AW. Comparative Efficacy of Targeted Systemic Therapies for Moderate to Severe Atopic Dermatitis without Topical Corticosteroids: An Updated Network Meta-analysis. Dermatology and Therapy. 2023. In Press.
38. Samynathan A, Fishbein AB, Abbott SM, Booster GD, Zee PC, Sheldon SH, Yosipovitch G, Silverberg JI. Assessment and management of sleep disturbances in atopic dermatitis: A review. Dermatitis. 2023. In Press.
39. Silverberg JI, Shi VY, Alexis A, Pierce E, Cronin A, McLean RR, Roberts-Toler C, Rueda MJ, Atwater AR, Simpson EL. Racial and ethnic differences in sociodemographic, clinical and treatment characteristics among patients with atopic dermatitis in the United States and Canada: Real-world data from the CorEvitas Atopic Dermatitis Registry. Dermatology and Therapy. 2023. In Press.
40. Patel KR, Justiz AM, Ahmed AM, Silverberg JI. Association of vitiligo and inflammatory arthropathy in hospitalized US adults. Journal of the American Academy of Dermatology. 2023. In Press.'
41. Silverberg JI, Armstrong A, Blauvelt A, Reich K. Longer-Term Efficacy and Safety in Clinical Trials of Systemic Agents Used to Treat Moderate to Severe AD. American Journal of Clinical Dermatology. 2023. In Press.
42. Silverberg JI, Lio PA, Simpson EL, Li C, Brownell D, Gryllos I, Ng-Cashin J, Krueger T, Swaiden V, Bliss R, Kim HD. Efficacy and safety of topically applied therapeutic ammonia oxidizing bacteria in adults with mild-to-moderate atopic dermatitis and moderate-to-severe pruritus: a randomized, double-blind, placebo-controlled, dose-ranging phase 2b trial. eClinicalMedicine. 2023. In Press.
43. Rios-Duarte JA, Sanchez-Zapata MJ, Silverberg JI. Association of vitiligo with multiple cutaneous and extra-cutaneous autoimmune diseases: A nationwide cross-sectional study. Archives of Dermatological Research. 2023. In Press.
44. Chong AC, Schwartz A, Lang J, Ong PY, Myles IA, Silverberg JI, Capozza K. Patients’ and Caregivers’ Preferences for Mental Health Care and Support in Atopic Dermatitis. Dermatitis. 2023. In Press.
45. Guttman-Yassky E, Silverberg JI, Thaçi D, Papp KA, Ständer S, Beck LA, Kim BS, Hu X, Liu J, Calimlim BM, Vigna N, Crowley JT, Teixeira HQ, Thyssen JP. Upadacitinib treatment withdrawal and retreatment in patients with moderate-to-severe atopic dermatitis: results from a phase 2b, randomized, controlled trial. Journal of the European Academy of Dermatology and Venereology. 2023. In Press.
46. Fonseca LSM, Filgueiras IS, Marques AHC, Vojdani E, Halpert G, Ostrinski Y, Baiocchi GC, Plaça DR; Freire PP, Pour SZ, Moll G, Catar R, Lavi YB, Silverberg JI, Zimmerman, de Miranda GC, Carvalho RF, Khan TA, Heidecke H, Dalmolin RJS, Luchessi AD, Ochs HD, Schimke LF, Amital H, Riemekasten G, Zyskind I, Rosenberg AZ, Vojdani A, Shoenfeld Y, Cabral-Marques O. Severe COVID-19 patients exhibit elevated levels of autoantibodies targeting cardiolipin and platelet glycoprotein with age: a systems biology approach. NPG Aging. 2023. In Press.
47. Smith-Norowitz TA, Silverberg JI, Abdelmajid H, Joks R, Kohlhoff S. CD1d expression on human monocytes of adults with allergic asthma or rhinoconjunctivitis. Annals of Clinical & Laboratory Science. 2023. 53:673-675.
48. Reich K, Silverberg J, Papp K, Deleuran M, Katoh N, Strober B, Beck LA, de Bruin-Weller M, Werfel T, Zhang F, Biswas P, DiBonaventura MD, Chan G, Johnson S, Farooqui SA, Kerkmann U, Clibborn C. Abrocitinib efficacy and safety in patients with moderate-to-severe atopic dermatitis: Results from phase 3 studies, including the long-term extension JADE EXTEND study. Journal of the European Academy of Dermatology and Venereology. 2023. In Press.
49. Simpson EL, Guttman-Yassky E, Eichenfield LF, Boguniewicz M, Bieber T, Schneider S, Guana A, Silverberg JI. Tralokinumab therapy for moderate-to-severe atopic dermatitis: Clinical outcomes with targeted IL-13 inhibition. Allergy. 2023. In Press.
50. Silverberg JI, de Bruin-Weller M, Calimlim BM, Hu X, Ofori SA, Platt AM, Teixeira HD, Eyerich K, Thyssen JP. Aggregate response benefit in skin clearance and itch reduction with upadacitinib or dupilumab in patients with moderate-to-severe atopic dermatitis. Journal of the European Academy of Dermatology and Venereology. 2023. In Press.
51. Reich K, Silverberg JI, Papp KA, Deleuran M, Katoh N, Strober B, Beck LA, de Bruin- Weller M, Werfel T, Zhang F, Biswas P, DiBonaventura MD, Chan G, Farooqui SA, Kerkmann U, Clibborn C. Abrocitinib effect on patient-reported outcomes in patients with moderate-to-severe atopic dermatitis: Results from phase 3 studies, including the long-term extension JADE EXTEND study. Journal of the European Academy of Dermatology and Venereology. 2023. In Press.
52. Myersa K, Silverberg JI, Joish V, Pierce A, Eichenfield L, Poulos C. Treatment Preferences Among Patients With Mild-to-Moderate Atopic Dermatitis. Journal of Dermatological Treatment. 2023. In Press.
53. Schneeweiss MC, Merola JF, Wyss R, Silverberg JI, Mostaghimi A. Venous thromboembolism in patients with bullous pemphigoid. JAMA Dermatology. 2023. In Press.
54. Silverberg JI, Simpson B, Abuabara K, Guttman-Yassky E, Calimlim B, Wegzyn C, Krueger W, Gamelli A, Munoz B, Faller RW, Crawford JM, Grada A, Eichenfield LF. Prevalence and Burden of Atopic Dermatitis Involving the Head, Neck, Face, and Hand: A Cross Sectional Study from the TARGET-DERM AD Cohort. Journal of the American Academy of Dermatology. 2023. In Press.
55. Gudmundsdóttir SL, Ballarini T, Ámundadóttir ML, Mészáros J, Hrafnkelsdóttir SK, Eysteinsdoóttir JH, Thorleifsdoóttir RH, Hrafnkelsdóttir SK, Oddsson S, Silverberg JI. Engagement, Retention and Acceptability in a Digital Health Program for Atopic Dermatitis: Prospective Interventional Study. JMIR Formative Research. 2023. In Press.
56. Simpson EL, Silverberg JI, Thyssen JP, Viguier M, Thaçi D, de Bruin-Weller M, Weidinger S, Chan G, DiBonaventura M, Biswas P, Feeney C, Koulias C, Cork MJ. Efficacy and Safety of Abrocitinib in Patients With Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial. American Journal of Clinical Dermatology. 2023. In Press.
57. Gooderham MJ, Pink AE, Simpson EL, Silverberg JI, Güler E, Watkins M. Abrocitinib 100 mg Once Daily for Moderate-to-Severe Atopic Dermatitis: A Review of Efficacy and Safety, and Expert Opinion on Use in Clinical Practice. Dermatology and Therapy. 2023. 13: 1893– 1907.
58. Silverberg JI, Horeczko J, Alexis A. Development of an Eczema Area and Severity Index atlas for diverse skin types. Dermatitis. 2023. In Press.
59. Nussbaum D, Chatrath S, Squirewell C, McCormick E, Sadur A, Desai S, Silverberg J, Friedman A. Participant Satisfaction of a Community-based Telehealth Clinic for Atopic Dermatitis. Journal of Drugs in Dermatology. 2023. In Press.
60. Choragudi S, Luis A, Silverberg JI, Yosipovitch G. Trends in healthcare utilization among United States children with 2 eczema by age, sex, race, and Hispanic ethnicity – National Health 3 Interview Survey 2006-2018]. Dermatitis. 2023. In Press.
61. Warshaw EM, Han J, Kullberg SA, DeKoven JG, Adler BL, Silverberg JI, Houle MC, Pratt MD, Belsito DV, Yu J, Botto NC, Reeder MJ, Taylor JS, Atwater AR, Dunnick CA, DeLeo VA, Mowad CM. Patch Testing to Chlorhexidine Digluconate, 1% Aqueous: NorthAmerican Contact Dermatitis Group Experience, 2015-2020. Dermatitis. 2023 Nov- Dec;34(6):501-508.
62. Warshaw EM, Peterson MY, Atwater AR, DeKoven JG, Pratt MD, Taylor JS, Belsito DV, Silverberg JI, Reeder MJ, DeLeo VA, Houle MC, Dunnick CA, Yu J, Adler B, Mowad C, Botto NC. Patch Testing to Paraphenylenediamine: The North American Contact Dermatitis Group Experience (1994-2018). Dermatitis. 2023 Jul 31. doi: 10.1089/derm.2023.0140. Online ahead of print.
63. Silverberg J, Jackson JM, Kirsner RS, Adiri R, Friedman G, Gao XH, Billings SD, Kerkmann U. Narrative Review of the Pathogenesis of Stasis Dermatitis: An Inflammatory Skin Manifestation of Venous Hypertension. Dermatologic Therapy. 2023. https://doi.org/10.1007/s13555-023-00908-0
64. Polaskey M, Bendelow, A, Mukherji J, Buranosky B, Silverberg JI, Fishbein AB. Facial atopic dermatitis is associated with increased rate and degree of sensitization to cow’s milk, egg whites, and peanuts in children under 36 months. Pediatric Dermatology. 2023. In Press.
65. Jourdan H, Silverberg JI. Correlation of clinician-reported outcomes with patient-reported outcomes by race and ethnicity in patients with atopic dermatitis. Journal of the American Academy of Dermatology. 2023. In Press.
66. Boguniewicz M, Fonacier L, Guttman-Yassky E, Ong PY, Silverberg JI. Atopic Dermatitis Yardstick Update. Annals of Allergy, Asthma and Immunology. 2023. In Press.
67. Wagner N, Loprete L, Duval V, Jauslin P, Benkali K, Silverberg JI, Wollenberg A, Saito T, Ahmad F, Graeber M, Winkelman W, Piketty C. Selection of Nemolizumab Clinical Dosage For Atopic Dermatitis. Journal of Drugs in Dermatology. 2023. In Press.
68. Sanfilippo E, Iyer S, Patel N, Silverberg JI. Assessment of racial and ethnic differences of atopic dermatitis characteristics in a diverse outpatient cohort in the United States. Journal of the American Academy of Dermatology. 2023. In Press.
69. Narla S, Silverberg JI. Which clinical measurement tools for atopic dermatitis severity make the most sense in clinical practice? Dermatitis. 2023. In Press.
70. Miot HA, Aoki V, Orfali RL, Solé D, Mallozi MC, Rodrigues TC, Silverberg JI. The (one- year) prevalence of atopic dermatitis in Brazil: a population-based survey by telephone. Journal of the European Academy of Dermatology and Venereology. 2023. In Press.
71. Lavi Y, Vojdani A, Halpert G, Sharif K, Ostrinski Y, Zyskind I, Lattin MT, Zimmerman J, Silverberg JI, Rosenberg AZ, Shoenfeld Y, Amital H. Dysregulated Levels of Circulating Autoantibodies Against Neuronal and Nervous System Autoantigens in COVID-19 Patients. Diagnostics. 2023. In Press.
72. Silverberg JI, Bissonnette R, Kircik L, Murrell DF, Selfridge A, Liu K, Ahluwalia G, Guttman-Yassky E. Efficacy and safety of etrasimod, a sphingosine 1-phosphate receptor modulator, in adults with moderate-to-severe atopic dermatitis (ADVISE). Journal of the American Academy of Dermatology and Venereology. 2023. In Press.
73. Blauvelt A, Thyssen JP, Guttman-Yassky E, Bieber T, Serra-Baldrich E, Simpson E, Rosmarin D, Elmaraghy H, Meskimen E, Natalie CR, Liu Z, Xu C, Pierce E, Morgan-Cox M, Garcia Gil E, Silverberg JI. Efficacy and Safety of Lebrikizumab in Moderate-to-Severe Atopic Dermatitis: 52-Week Results of Two Randomized, Double-Blinded, Placebo- Controlled Phase 3 Trials. British Journal of Dermatology. 2023. In Press.
74. Baiocchi GC, Vojdani A, Rosenberg AZ, Vojdani E, Halpert G, Ostrinski Y, Zyskind I, Filgueiras IS, Schimke LF, Marques AHC, Giil LM, Lavi YB, Silverberg JI, Zimmerman J, Hill DA, Thornton A, Kim M, De Vito R, Fonseca DLM, Plaça DR, Freire PP, Camara NOS, Calich VLG, Scheibenbogen C, Heidecke H, Lattin MT, Ochs HD, Riemekasten G, Amital H, Cabral-Marques O, Shoenfeld Y. Cross-sectional analysis reveals autoantibody signatures associated with COVID-19 severity. Journal of Medical Virology. 2023. In Press.
75. Jackson-Cowan L, Silverberg JI. Longitudinal Course of Cognitive Impairment in Patients with Atopic Dermatitis. Archives of Dermatological Research. 2023. In Press.
76. Bissonnette R, Eichenfield LF, Simpson E, Thaçi D, Kabashima K, Thyssen JP, Guttman- Yassky E, Nunes FP, Gamalo M, Ahmad F, Kuligowski M, Sun K, Pipper C, Christensen AW, D’Angelo P, Milutinovic M, Guettner A, Silverberg JI. Estimands for atopic dermatitis clinical trials: expert opinion on the importance of intercurrent events. Journal of the European Academy of Dermatology and Venereology. 2023. In Press.
77. Christensen MO, Barakji YA, Loft N, Egeberg A, Thomsen SF, Silverberg JI, Flohr C, Maul JT, Schmid-Grendelmeier P, Halling AS, Vittrup I, Thyssen JP. Prevalence of and association between atopic dermatitis and food sensitivity, food allergy and challenge-proven food allergy: A systematic review and meta-analysis. Journal of the European Academy of Dermatology and Venereology. 2023. In Press.
78. Sofen H, Bissonnette R, Yosipovitch G, Silverberg JI, Tyring S, Loo WJ, Zook M, Lee M, Zou L, Jiang GL, Paolini JF. Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled phase 2a study. eClinicalMedicine. 2023. In press.
79. Pecora VA, McCormick ET, Carrington AE, Sodha P. Evaluating the content and quality of the top 50 #cosmeticdermatology Instagram posts. Accepted to Dermatologic Surgery 11/20/2023.
80. Sodha P, Wang JV, Aboul-Fettouh N, Martin K, Geronemus RG, Friedman PM. Largest Comparative Analysis: Novel Large Spot 595nm, high energy, pulsed dye laser reduces number of treatments for improvement of adult and pediatric port wine birthmarks. Lasers Surg Med. June 2023. doi: 10.1002/lsm.23693
81. Desai S, McCormick E, Sodha P, Friedman A. Shining a Light on Vitiligo and Associated Comorbidities: What Is the Evidence? J Drugs Dermatol. 2023;22(4):428-430.
82. Kubicki SL, Guo EL, Sodha P, Richmond H, Friedman PM. Combination 1550nm non-ablative fractional resurfacing and laser hair removal for treatment of Becker’s nevi in skin types III-IV. Lasers Surg Med.2023;55(1): 99-104.
83.Mays D, Friedman A, Kennedy J, Yiannias J, Morgan J. Non-adherence to Labeling Standards Can Misrepresent Safety of Ingredients in Cosmetic Cleansers. J Drugs Dermatol. 2023 Jan 1;22(1):98-100.
84.Anadkat MJ, Lacouture M, Friedman A, Horne ZD, Jung J, Kaffenberger B, Kalmadi S, Ovington L, Kotecha R, Abdullah HI, Grosso F. Expert guidance on prophylaxis and treatment of dermatologic adverse events with Tumor Treating Fields (TTFields) therapy in the thoracic region. Front Oncol. 2023;12:97547.
85.McCormick E, Desai S, Friedman A. Practical Approaches to the Diagnosis and Management of Sensitive Skin: A Scoping ReviewJ Drugs Dermatol. 2023; 22(2):228-230
86. Yosipovitch G, Nedorost ST, Silverberg JI, Friedman AJ, Canosa JM, Cha A. Stasis Dermatitis: An Overview of Its Clinical Presentation, Pathogenesis, and Management. Am J Clin Dermatol. 2023 Feb 17. doi: 10.1007/s40257-022-00753-5.
87.Kircik L, Tanghetti EA, Friedman A, Kucera K, Jacobson A. Challenges in Psoriatic Disease Addressed by Fixed-Combination Halobetasol Propionate 0.01% and Tazarotene 0.045% Lotion J Clin Aesthet Dermatol. 2023;16(3):21-26.
88.Desai S, McCormick E, Sodha P, Friedman A. Shining a Light on Vitiligo and Associated Comorbidities: What Is the Evidence? J Drugs Dermatol. 2023. 1;22(4):428-430.
89.Desai S, McCormick E, Nelson K, et al. EXTRA, EXTRA, treatment approaches for EXTRAmammary Paget disease. J Drugs Dermatol. 2023;22(8):844-845.
90.Friedman A. Subclinical sensitization with diphenylcyclopropenone is sufficient for the treatment of alopecia areata: Retrospective analysis of 159 cases. J Am Acad Dermatol. 2023:S0190-9622(23)02510-0
91.Friedman A. JAAD Game Changers: Pityrosporum folliculitis: A retrospective review of 110 cases. J Am Acad Dermatol. 2023:S0190-9622(23)02508-2. 247.Friedman A. Cause-specific mortality in adults with atopic dermatitis. J Am Acad Dermatol. 2023:S0190-9622(23)02505-7.
92.McCormick ET, Desai S, Nelson K, Friedman A. Fractional Laser for Prevention of Non-melanoma Skin Cancer.J Drugs Dermatol. 2023. 1;22(9):953-954. 249.McCormick ET, Draganski A, Chalmers S, Zahn J, Garcia S, Nussbaum D, Friedman A, Putterman C, Friedman. Nano-encapsulated anandamide reduces inflammatory cytokines in vitro and lesion severity in a murine model of cutaneous lupus erythematosus. J. Exp Dermatol. 2023 Sep 19. doi: 10.1111/exd.14935. Online ahead of print.
93.Yosipovitch G, Jackson JM, Nedorost ST, Friedman AJ, Adiri R, Cha A, Canosa JM. Stasis Dermatitis: The Burden of Disease, Diagnosis, and Treatment. Dermatitis. 2023 Sep 29. doi: 10.1089/derm.2022.0076. Online ahead of print.
94.Whiting C, Azim SA, Friedman A. Updates in the Treatment of Body-Focused Repetitive Disorders. J Drugs Dermatol. 2023. 1;22(10):1069-1070.
95.Greenzaid J, Nussbaum D, Friedman A. Keratosis Pilaris: Treatment Practices of Board-Certified Dermatologists. J Drugs Dermatol. 2023. 1;22(10):985-989.
96.Nussbaum D, Chatrath S, Squirewell C, McCormick E, Sadur A, Desai S, Silverberg J, Friedman A. Participant Satisfaction of a Community-based Telehealth Clinic for Atopic Dermatitis. J Drugs Dermatol. 2023, 1;22(10):1066-1067.
97.McCormick E, Nussbaum D, Desai S, Friedman A. Evaluating Quality and Reliability of Most-Viewed YouTube Videos on Topical Steroid Withdrawal. J Drugs Dermatol. 2023.1;22(11):1128-1129.
98.Azim SA, Whiting C, Friedman A. Platelet-Rich Plasma Across the Spectrum of Alopecias: Where Are We Now? J Drugs Dermatol. 2023 Nov 1;22(11):1134-1137.
99.Whiting C, Azim SA, Friedman A. Not So Vanilla: What Dermatologists Should Know About Vanilloid Receptors. J Drugs Dermatol. 2023.1;22:1237-1238. .
2022
1. Yosipovitch G, Nedorost ST, Silverberg JI, Friedman AJ, Canosa JM, Cha A. Stasis Dermatitis: An Overview of Its Clinical Presentation, Pathogenesis, and Management. American Journal of Clinical Dermatology. 2022. In Press.
2. Jacobs M, Karp A, Alessandro C, Ganz M, Glatt A, Rosenberg A, Wang R, Zimmerman J, Silverberg J, Zyskind I. SARS-CoV-2 Infection in Winter 2021/2022: The Association of Varying Clinical Manifestations With and Without Prior Vaccination. Cureus. 2022. In Press.
3. Sidbury R, Alikhan A, Bercovitch L, Cohen DE, Darr JM, Drucker AM, Eichenfield LF, Frazer-Green L, Paller AS, Schwarzenberger K, Silverberg JI, Singh AM, Wu PA, Davis DMR. Guidelines of care for the management and treatment of atopic dermatitis in adults with topical therapies. Journal of the American Academy of Dermatology. 2022. In Press.
4. Silverberg JI, Lynde CW, Abuabara K, Patruno C, De Benedetto A, Zhang H, Thomas RB, Bégo-Le-Bagousse G, Khokhar FA, Vakil J, Rodríguez Marco A, Levit NA. Efficacy and Safety of Dupilumab Maintained in Adults ≥60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials. American Journal of Clinical Dermatology. 2022. In Press.
5. Thyssen JP, Halling AS, Schmid-Grendelmeier P, Guttman-Yassky E, Silverberg JI. Comorbidities of atopic dermatitis– what does the evidence say? Journal of Allergy and Clinical Immunology. 2022. In Press.
6. Narla S, Heath CR, Alexis A, Silverberg JI. Racial disparities in dermatology. Archives of Dermatological Research. 2022. In Press.
7. Silverberg JI, Chaubal M, Warshaw EM, Maibach HI, Belsito DV, DeKoven JG, Zug KA, Taylor JS, Sasseville D, DeLeo VA, Pratt MD, Reeder MJ, Atwater AR, Fowler JF, Houle MC. Prevalence and Trend of Allergen Sensitization in Patients with Cheilitis Referred for Patch Testing, North American Contact Dermatitis Group Data, 2001-2018. Contact Dermatitis. 2022. In Press.
8. Silverberg JI, French LE, Warren RB, Strober B, Kjøller K, Sommer MOA, Andres P, Felding J, Weiss A, Tutkunkardas D, Skak-Nielsen T, Guttman-Yasky E. Pharmacology of orismilast, a potent and selective PDE4 inhibitor. Journal of the European Academy of Dermatology and Venereology. 2022. In Press.
9. Rangel SM, Kim T, Sheth A, Blumstein A, Lai JS, Cella D, Paller AS, Silverberg J KO/Prevalence and associations of fatigue in pediatric atopic dermatitis: a cross-sectional study. Journal of the European Academy of Dermatology and Venereology. 2022. In Press.
10. Silverberg JI, Lynde CW, Abuabara K, Patruno C, De Benedetto A, Zhang H, Thomas RB, Bégo-Le-Bagousse G, Khokhar FA, Vakil J, Rodríguez Marco A, Levit NA. Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials. American Journal of Clinical Dermatology. 2022. In Press.
11. Warren RB, Strober B, Silverberg JI, Guttman E, Andres P, Felding J, Tutkunkardas D, Kjøller K, Sommer MOA, French LE. Oral orismilast: Efficacy and safety in moderate-to- severe psoriasis and development of modified release tablets. Journal of the European Academy of Dermatology and Venereology. 2022. In Press.
12. Thyssen JP, Ross Terres JA, Pierce EJ, Feely MA, Silverberg JI. Prevalence, incidence, and relative risk of cardiovascular disease risk factors in adults with atopic dermatitis: a systematic review. Journal of the European Academy of Dermatology and Venereology. 2022. In Press.
13. Chovatiya R, Smith Begolka W, Thibau IJ, Silverberg JI. The Financial Burden of Out-Of- Pocket Healthcare Expenses on Caregivers of Children with Atopic Dermatitis in the United States. Skin Health and Disease. 2022. In Press.
14. Silverberg JI, Simpson EL, Calimlim BM, Litcher-L, Li X, Sun X, Leshem YA. Determining Severity Strata for Three Atopic Dermatitis Patient-Reported Outcome Questionnaires: Defining Severity Score Ranges for the Worst Pruritus Numerical Rating Scale and the Atopic Dermatitis Symptom and Impact Scales (ADerm-SS and ADerm-IS). Dermatology and Therapy. 2022. In Press.
15. Rios J, Silverberg JI. Association of adult atopic dermatitis severity with bacterial, viral and fungal skin infections. Dermatitis. 2022. In Press.
16. Silverberg JI, Guttman-Yassky E, Thaci D, Irvine AD, Stein Gold L, Blauvelt A, Simpson EL, Chu CY, Liu Z, Gontijo Lima R, Pillai SG, Seneschal J. Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis. New England Journal of Medicine. 2022. In Press.
17. Iyer S, Patel N, Sanfillipo E, Dellavalle RP, Silverberg JI. Assessment of the validity of international classification of disease tenth revision codes for atopic dermatitis. Archives of Dermatological Research. 2022. In Press.
18. Maleki-Yazdi K, Heen AF, Zhao IX, Suzumura EA, Makhdami N, Guyatt GH, Winders T, Wheeler KE, Wang J, Spergel J, Silverberg JI, Ong PY, O’Brien M, Martin SA, Lio P, Lind ML, LeBovidge J, Kim E, Huynh J, Greenhawt M, Frazier WT, Ellison K, Chen L, Capozza K, De Benedetto A, Boguniewicz M, Smith Begolka W, Lebovidge J, Boguniewicz M, Asiniwasis RN, Schneider L, Chu DK. Values and preferences of patients and caregivers regarding treatment of atopic dermatitis. JAMA Dermatology. 2022. In Press.
19. Silverberg JI, Mohawk JA, Cirulli J, Nograles K, Punzalan JC, Kelly KM, Kim BS, Guttman-Yassky E, Lebwohl M. Burden of Disease and Unmet Needs in Atopic Dermatitis (BAND-AD): Results From a Patient Survey. Dermatitis. 2022. In Press. 20. Narla S, Silverberg JI. Safety of oral Janus Kinase inhibitors in the treatment of moderate to severe atopic dermatitis. Dermatitis. 2022. In Press.
21. Gudmundsdottir SL, Ballarini T, Amundadottir ML, Meszaros J, Eysteinsdottir JH, Thorleifsdottir RH, Hrafnkelsdottir SK, Bragadottir HB, Oddsson S, Silverberg JI. Clinical Efficacy of a Digital Intervention for Patients with Atopic Dermatitis: a Prospective Single- Center Study. Dermatology and Therapy. 2022. In Press.
22. Simpson E, Armstrong A, Boguniewicz M, Chiesa Fuxench ZC, Feely M, Pierce E, Sun L, Chen YF, Angle R, Silverberg JI. Baricitinib 2 mg for the treatment of atopic dermatitis in North America: Long-term efficacy and patient-reported outcomes. Dermatologic Therapy. 2022. In Press.
23. Weidinger S, Simpson EL, Silverberg JI, Schmitt J, Leshem YA, Katoh N, Chen Z, Zhang H, Shumel B, Bansal A, Chao J, Lu Y, Rossi AB, Abramova A. Efficacy of Dupilumab in Moderate and Severe Atopic Dermatitis. Journal of Allergy and Clinical Immunology: In Practice. 2022. In Press.
24. Warshaw EM, Xiong M, DeKoven JG, Taylor JS, Belsito DV, Reeder MJ, Adler BL, Pratt MD, Atwater AR, Maibach HI, Silverberg JI, Yu J, Botto N, Fowler JF, Houle MC, Mowad CM, Dunnick CA, DeLeo VA. Co-reactivity of Glucosides: Retrospective Analysis of North American Contact Dermatitis Group Data 2019-2020. Contact Dermatitis. 2022. In Press.
25. Warshaw EM, Xiong M, Belsito DV, Adler BL, Atwater AR, DeKoven JG, Taylor JS, Reeder MJ, Houle MC, Silverberg JI, Pratt MD, Dunnick CA, Botto N, DeLeo VA, Mowad CM, Maibach HI, Yu J, Fowler JF. Patch Testing with Benzophenone-3 and 4: The North American Contact Dermatitis Group Experience, 2013-2020. Dermatitis. 2022. In Press.
26. Devasenapathy N, Chu A, Wong M, Srivastava A, Ceccacci R, Lin C, McDonald M, Wen A, Steen J, Levine M, Pyne L, Ibrahim Q, Wheeler KE, Wang J, Spergel J, Silverberg JI, Ong PY, O’Brien M, Martin SA, Lio P, Lind ML, LeBovidge J, Kim E, Huynh J, Greenhawt M, Frazier WT, Ellison K, Chen L, Capozza K, De Benedetto A, Boguniewicz M, Smith- Begolka W, Asiniwasis RN, Schneider L, Chu DK. Cancer risk with topical pimecrolimus and tacrolimus for atopic dermatitis: GRADE systematic review and Bayesian meta-analysis of randomized and observational studies. Lancet Child and Adolescent Health. 2022. InPress.
27. Rakita U, Kaundinya T, Silverberg JI. Associations between shower and moisturizing practices with atopic dermatitis severity: a prospective longitudinal cohort study. Dermatitis. 2022. In Press.
28. Reich K, Simpson EL, Wollenberg A, Bissonnette R, Masatoshi A, Cardillo T, Janes J, Sun L, Chen S, Silverberg JI. Efficacy of downtitration or treatment withdrawal compared to continuous dosing after successful treatment with baricitinib in patients with moderate-to- severe atopic dermatitis in a randomised substudy from the long-term extension study, BREEZE-AD3. British Journal of Dermatology. 2022. In Press
29. Bloudek L, Eichenfield LF, Silverberg JI, Joish VN, Lofland JH, Sun K, Augustin M, Migliaccio-Walle K, Sullivan SD. Impact of ruxolitinib cream on work productivity and activity impairment and associated indirect costs in patients with atopic dermatitis: Pooled results from two phase 3 studies. American Journal of Clinical Dermatology. 2022. In Press.
30. Guttman-Yassky E, Thyssen JP, Silverberg JI, Papp KA, Paller AS, Weidinger S, Hong C, Hendrickson B, Dilley D, Tenorio AR, Ladizinski B, Chu AD, Liu J, Irvine AD. Safety of upadacitinib in moderate-to-severe atopic dermatitis: An integrated analysis of phase 3 studies. Journal of Allergy and Clinical Immunology: In Practice. 2022. In Press.
31. Paller AS, Silverberg JI, Cork MJ, Guttman-Yassky E, Lockshin B, Irvine AD, Kim MB, Kabashima K, Chen Z, Lu Y, Bansal A, Rossi AB, Shabbir A. Efficacy and Safety of Dupilumab in Patients With Erythrodermic Atopic Dermatitis. JAMA Dermatology. 2022. In Press.
32. Chovatiya R, Begolka WS, Thibau IJ, Silverberg JI. Atopic Dermatitis Polypharmacy and Out-Of-Pocket Healthcare Expenses. Journal of Drugs in Dermatology. 2022. In Press.
33. Shareef SJ, Rehman R, Haque M, Silverberg JI. Readability, Understandability, and Actionability of Online Patient Education Materials for Sunscreen. Archives of Dermatological Research. 2022. In Press.
34. DeKoven J, Warshaw E, Reeder M, Atwater A, Silverberg JI, Belsito DV, Sasseville D, Zug K, Taylor J, Pratt M, Maibach H, Fowler J, Adler B, Houle MC, Mowad C, Botto N, Yu J, Dunnick C. North American Contact Dermatitis Group Patch Test Results: 2019 - 2020. Dermatitis. 2022. In Press.
35. Blauvelt A, Gooderham M, Bhatia N, Langley RG, Schneider S, Zoidis J, Kurbasic A, Armstrong A, Silverberg JI. Tralokinumab Efficacy and Safety, with or without Topical Corticosteroids, in North American Adults with Moderate-to-Severe Atopic Dermatitis: A Subanalysis of Phase 3 Trials ECZTRA 1, 2, and 3. Dermatology and Therapy. 2022. In Press.
36. Chatrath S, Silverberg JI. Phenotypic Differences of Atopic Dermatitis Stratified by Age. Journal of the American Academy of Dermatology International. 2022. In Press.
37. Ramírez-Marín HA, Singh AM, Ong PY, Silverberg JI. Food Allergy Testing in Atopic Dermatitis. Journal of the American Academy of Dermatology International. 2022. In Press.
38. Yepes-Nuñez JJ, Guyatt GH, Gómez-Escobar LG, Pérez-Herrera LC, Chu A, Ceccaci R, Acosta-Madiedo AS, Wen A, Moreno-López S, MacDonald M, Barrios M, Chu X, Islam N, Gao Y, Wong M, Gaviria-Valencia S, Ochoa-Montero H, Romero SG, Couban R, Oykhman P, Chen L, Winders T, Asiniwasis R, Boguniewicz M, DeBenedetto A, Ellison K, Frazier W, Greenhawt M, Huynh J, Kim E, LeBovidge J, Lind ML, Lio P, Martin S, O’Brien M, Ong P, Silverberg JI, Spergel J, Wang J, Wheeler K, Schneider L, Chu DK. Allergen Immunotherapy for Atopic Dermatitis: A Systematic Review and Meta-Analysis of Benefits and Harms. Journal of Allergy and Clinical Immunology. 2022. In Press.
39. Blauvelt A, Szepietowski JC, Papp K, Simpson EL, Silverberg JI, Kim BS, Kwatra SG, Kuligowski ME, Venturanza ME, Wei S, Kircik L. Itch-Free State in Patients With Atopic Dermatitis Treated With Ruxolitinib Cream: Pooled Analysis From Two Randomized Phase 3 Studies. Journal of the American Academy of Dermatology. 2022. In Press.
40. Silverberg JI, Boguniewicz M, Hanifin J, Papp KA, Zhang H, Rossi AB, Levit NA. Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis is Efficacious Regardless of Age of Disease Onset. Dermatology and Therapy. 2022. In Press.
41. Kaundinya T, Rakita U, Silverberg JI. Prevalence, predictors and longitudinal course of sexual dysfunction in adults with atopic dermatitis. Dermatitis. 2022. In Press.
42. Silverberg JI, Zyskind I, Naiditch H, Zimmerman J, Glatt AE, Pinter A, Theel AS, Joyner MJ, Hill A, Lieberman MR, Bigajer E, Stok D, Frank E, Rosenberg AZ. Predictors of chronic COVID-19 symptoms in a community-based cohort of adults. PLOS One. 2022. In Press.
43. Silverberg JI, Feldman SR, Begolka WS, Johnson MB, Stanojev C, DiBonaventura M, Cella RR, Valdez H, Feeney C, Thyssen JP. Patient perspectives of atopic dermatitis: comparative analysis of terminology in social media and scientific literature, identified by a systematic literature review. British Journal of Dermatology. 2022. In Press.
44. Blauvelt A, Kircik L, Papp K, Simpson EL, Silverberg JI, Kim BS, Kwatra SG, Kuligowski ME, Venturanza ME, Wei S, Szepietowski JC. Rapid Pruritus Reduction With Ruxolitinib Cream Treatment in Patients With Atopic Dermatitis. Journal of the European Academy of Dermatology and Venereology. 2022. In Press.
45. Silverberg JI, Patel N, Warshaw EM, Maibach HI, Belsito DV, DeKoven JG, Zug KA, Taylor JS, Sasseville D, DeLeo VA, Pratt MD, Reeder MJ, Atwater AR, Fowler JF, Houle MC. Patch testing with Cobalt in Children and Adolescents: North American Contact Dermatitis Group experience, 2001 to 2018. Contact Dermatitis. 2022. In Press.
46. Silverberg JI, Patel N, Warshaw EM, DeKoven JG, Belsito DV, Atwater AR, Taylor JS, Sasseville D, Reeder MJ, Houle MC, DeLeo VA, Maibach HI, Fowler JF, Zug KA, Pratt MD. Patch testing with Cobalt in Adults: North American Contact Dermatitis Group experience, 2001 to 2018. Dermatitis. 2022. In Press.
47. Silverberg JI, Patel N, Warshaw EM, DeKoven JG, Belsito DV, Atwater AR, Houle MC, Taylor JS, Reeder MJ, Zug KA, Sasseville D, DeLeo VA, Pratt MD, Fowler JF, Maibach HI. Hand and foot dermatitis in patients referred for patch testing: Analysis of North American Contact Dermatitis Group Data, 2001-2018. Journal of the American Academy of Dermatology. 2022. In Press.
48. Simpson EL, Wollenberg A, Soong W, Steffensen LA, Kurbasic A, Schneider S, Zoidis J, Silverberg JI. Patient-oriented measures for phase 3 studies of tralokinumab for treatment of atopic dermatitis (ECZTRA 1, 2 and 3). Annals of Allergy, Asthma and Immunology.2022. In Press.
49. Simpson EL, Merola JF, Silverberg JI, Reich K, Warren RB, Staumont-Sallé D, Girolomoni G, Papp K, de Bruin-Weller M, Thyssen JP, Zachariae R, Olsen CK, Wollenberg A. Safety of Tralokinumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis: Pooled Analysis of Five Randomized, Double-blind, Placebo-controlled Phase 2 and Phase 3 Trials. British Journal of Dermatology. 2022. In Press.
50. Silverberg JI, Adam DN, Zirwas M, Kalia S, Gutermuth J, Pinter A, Pink AE, Chiricozzi A, Barbarot S, Mark T, Tindberg AM, Weidinger S. Tralokinumab Plus Topical Corticosteroids as Needed Over a 32-week Period Provides Progressive and Sustained Efficacy in Adults With Moderate-to-Severe Atopic Dermatitis. American Journal of Clinical Dermatology. 2022. In Press.
51. Chovatiya R, Silverberg JI. Evaluating the Longitudinal Course of Atopic Dermatitis: Implications for Clinical Practice. American Journal of Clinical Dermatology. 2022. InPress.
52. Gooderham MJ, Girolomoni G, Moore JO, Silverberg JI, Bissonnette R, Forman S, Peeva E, Biswas P, Valdez H, Chan G. Durability of Response to Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis After Treatment Discontinuation in a Phase 2b Trial. Dermatology & Therapy. 2022. In Press.
53. Oykhman P, Dookie J, Al-Rammahy H, De Benedetto A, Asiniwasis RN, LeBovidge J, Wang J, Ong PY, Lio P, Gutierrez P, Capozza K, Kim E, Martin SA, Frazier W, Boguniewicz M, Spergel JM, Greehawt M, Silverberg JI, Schneider L, Chu DK. Dietary elimination for the treatment of atopic dermatitis. Journal of Allergy and Clinical Immunology: In Practice. 2022. In Press.
54. Warshaw EM, Xiong M, Atwater AR, DeKoven JG, Pratt MD, Maibach HI, Taylor JS, Belsito DV, Silverberg JI, Reeder MJ, Zug KA, Sasseville D, Fowler JF, DeLeo VA, Houle MC, Dunnick CA. Patch Testing with Glucosides: The North American Contact Dermatitis Group Experience, 2009-2018. Journal of the American Academy of Dermatology. 2022. In Press.
55. Barbarot S, Silverberg JI, Gadkari A, Simpson EL, Weidinger S, Mina-Osorio P, Rossi AB, Brignoli L, Mnif T, Guillemin I, Fenton MC, Pellan M, Mahajan P, Delevry D, Bansal A, Eckert L. The Family Impact of Atopic Dermatitis (AD) in the Pediatric Population: Results from an International Cross-sectional Study. Journal of Pediatrics. 2022. 2022 Jul;246:220-226.
56. Simpson EL, Bissonnette R, Paller AS, King B, Silverberg JI, Reich K, Thyssen JP, Doll H, Sun L, DeLozier AM, Nunes FP, Eichenfield LF. The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-ADTM): A Clinical Outcome Measure for the Severity of Atopic Dermatitis. British Journal of Dermatology. 2022. In Press.
57. Duan GY, Silverberg JI. Sleep impairment in patients with chronic inflammatory skin diseases: A review of mechanisms and management. Journal of the American Academy of Dermatology. 2022. In Press.
58. Chatrath S, Lei D, Yousaf M, Chavda R, Gabriel S, Silverberg JI. Longitudinal course and predictors of depressive symptoms in atopic dermatitis. Journal of the American Academy of Dermatology. 2022. In Press.
59. Silverberg JI, Hong HC, Thyssen JP, Calimlim BM, Joshi A, Teixeira HD, Collins EB, Crowell MM, Johnson SJ, Armstrong AW. Comparative Efficacy of Targeted Systemic Therapies for Moderate to Severe Atopic Dermatitis without Topical Corticosteroids: Systematic Review and Network Meta-analysis. Dermatology and Therapy. 2022. In Press.
60. Rokni AM, Ayasse M, Ahmed A, Guggina L, Kantor RW, Silverberg JI. Association of Autoimmune Blistering Disease and Specifically, Pemphigus Vulgaris, with Cardiovascular Disease and its Risk Factors: A Systematic Review and Meta-analysis. Archive of Dermatological Research. 2022 Mar 9. doi: 10.1007/s00403-022-02346-y. Online ahead of print.
61. Silverberg JI / Patel N, Warshaw EM, DeKoven JG, Atwater AR, Belsito DV, Dunnick CA, Houle MC, Reeder MJ, Maibach HI, Zug KA, Taylor JS, Sasseville D, Fransway AF, DeLeo VA, Pratt MD, Fowler JF, Zirwas MJ. Lanolin Allergic Reactions: North American Contact Dermatitis Group experience, 2001 to 2018. Dermatitis. 2022. In Press.
62. Rakita U, Kaundinya T, Silverberg JI. Assessment of adherence to skin care recommendations in clinical practice: a real-world observational study. Journal of the American Academy of Dermatology. 2022 Feb 15:S0190-9622(22)00273-0. doi: 10.1016/j.jaad.2022.02.019. Online ahead of print.
63. Ramírez-Marín HA, Silverberg JI. Differences between Pediatric and Adult Atopic Dermatitis. Pediatric Dermatology. 2022 Mar 16. doi: 10.1111/pde.14971. Online ahead of print.
64. Schneeweiss MC, Kirchgesner J, Wyss R, Jin Y, York C, Merola J, Mostaghimi A, Silverberg JI, Schneeweiss S, Glynn R. Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases: a US cohort study with propensity-score adjustment. British Journal of Dermatology. 2022. In Press.
65. Bakaa L, Pernica JM, Couban RJ, Tackett KJ, Burkhart CN, Leins L, Smart J, Garcia- Romero MT, Elizalde-Jiménez IG, Herd M, Asiniwasis RN, Boguniewicz M, De Benedetto A, Chen L, Ellison K, Frazier W, Greenhawt M, Huynh J, LeBovidge J, Laura Lind M, Lio P, O'Brien M, Ong PY, Silverberg JI, Spergel JM, Wang J, Smith Begolka W, Schneider L, Chu DK. Bleach baths for atopic dermatitis: a systematic review and meta-analysis. Annals of Allergy, Asthma and Immunology. 2022 Mar 30:S1081-1206(22)00286-1. doi: 10.1016/j.anai.2022.03.024. Online ahead of print.
66. Chovatiya R, Silverberg JI. Evaluating the Longitudinal Course of Atopic Dermatitis: a review of the literature. Journal of the American Academy of Dermatology. 2022 Feb 10:S0190-9622(22)00253-5. doi: 10.1016/j.jaad.2022.02.005. Online ahead of print.
67. Narla S, Silverberg JI. The suitability of treating atopic dermatitis with Janus kinase inhibitors. Expert Review of Clinical Immunology. 2022 Apr 4. doi: 10.1080/1744666X.2022.2060822. Online ahead of print.
68. Davis DMR, Drucker AM, Alikhan A, Bercovitch L, Cohen DE, Darr JM, Eichenfield LF, Frazer-Green L, Paller AS, Silverberg JI, Singh AM, Sidbury R. AAD Guidelines: awareness of comorbidities associated with atopic dermatitis in adults. Journal of the American Academy of Dermatology. 2022 Jan 24;S0190-9622(22)00080-9. doi: 10.1016/j.jaad.2022.01.009. Online ahead of print.
69. Ständer S, Bhatia N, Gooderham MJ, Silverberg JI, Thyssen JP, Biswas P, DiBonaventura M, Romero W, Farooqui A. High threshold efficacy responses in moderate- to-severe atopic dermatitis are associated with additional quality of life benefits: pooled analyses of abrocitinib monotherapy studies in adults and adolescents. Journal of the European Academy of Dermatology and Venereology. 2022. In Press.
70. Schneeweiss MC, Silverberg JI, Mostaghimi A. Venous Thromboembolism in Chronic Inflammatory Skin Diseases-The Need to Consider Bullous Pemphigoid-Reply. JAMA Dermatology. 2022. 158(3): 331-332.
71. Wollenberg A, Marcoux D, Silverberg JI, Aoki V, Baselga E, Zhang H, Levit NA, Taieb A, Rossi AB. Dupilumab provides rapid and sustained improvement in SCORAD outcomes in pediatric patients with atopic dermatitis. Acta Dermatology and Venereology. 2022. 33(1): 266-277.
72. Yosipovitch G, Papp K, Forman K, Han G, Waibel J, Rueda MJ, Sun L, Chen YF, Goldblum O, Pierce E, Silverberg JI. The contribution of itch and skin severity improvements to the Dermatology Life Quality Index in patients with atopic dermatitis in baricitinib phase 3 trials. British Journal of Dermatology. 2022 Jan 18. doi: 10.1111/bjd.21015. Online ahead of print.
73. Chovatiya R, Smith Begolka W, Thibau IJ, Silverberg JI. Response Letter to the Editor: Impact and Associations of Atopic Dermatitis Out-of-Pocket Health Care Expenses in the United States. Dermatitis. 2022 Mar 22. doi: 10.1097/DER.0000000000000875. Online ahead of print.
74. Manjunath J, Lei D, Ahmed A, Ayasse M, Chavda R, Gabriel S, Silverberg JI. Longitudinal course of sleep disturbance and relationship with itch in adult atopic dermatitis in clinical practice. Dermatitis. 2022 Mar 3. doi: 10.1097/DER.0000000000000859. Online ahead of print.
75. Manjunath J, Silverberg NB, Silverberg JI. Association of atopic dermatitis with poor school behaviors in US children and adolescents. Journal of the European Academy of Dermatology and Venereology. 2021 Nov 28. doi: 10.1111/jdv.17840. Online ahead of print.
76. Manjunath J, Silverberg JI. Association of atopic dermatitis with delinquent behaviors in US children and adolescents. Archives of Dermatological Research. 2022 Jan 10. doi: 10.1007/s00403-021-02314-y. Online ahead of print.
77. Credle JJ, Gunn J, Sangkhapreecha P, Monaco DR, Zheng XA, Tsai HJ, Wilbon A, Morgenlander WR, Rastegar A, Dong Y, Jayaraman S, Tosi L, Parekkadan B, Baer AN, Roederer M, Bloch EM, Tobian AAR, Zyskind I, Silverberg JI, Rosenberg AZ, Cox AL, Lloyd T, Mammen AL, Larman HB. Unbiased discovery of autoantibodies associated with severe COVID-19 via genome-scale self-assembled DNA-barcoded protein libraries Nature Biomedical Engineering. 2022. In Press.
78. Schneeweiss MC, Wyss R, Chin K, Merola JF, Silverberg JI, Mostaghimi A, Schneeweiss S. Incidence of Bacterial and Nonbacterial Conjunctivitis in Patients With Atopic Dermatitis Treated With Dupilumab: A US Multidatabase Cohort Study. Dermatitis. 2022 Feb 15. doi: 10.1097/DER.0000000000000843. Online ahead of print.
79. Cabral-Marquesa O, Halpertd G, Schimkea LF, Ostrinskio Y, Baiocchia GC, Freirea PP, Filgueirasa IS, Zyskinde I, Latting MT, Tranh F, Schreiberh S, Marquesa AHC, Plaçab DR, Fonsecab DLM, Humrichi JY, Mülleri A, Giilj LM, Grabhoffi H, Schumanni A, Hackeli AM, Junkerk J, Meyerk C, Ochsl HD, Lavim YB, Scheibenbogenn C, Dechendo R, Jurisicap I, Schulze-Forsterk K, Silverberg JI, Amital H, Zimmerman J, Heideckek H, Rosenberg AZ, Riemekasteni G, Shoenfeld Y. Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity. Nature Communications. 2022 Mar 9;13(1):1220. doi: 10.1038/s41467-022-28905-5.
80. Hua T / Kim LS, Yousaf M, Gwillim EC, Yew YW, Lee B, Hua K, Erickson T, Cheng B, Patel K, Silverberg JI. Psychological interventions are more effective than educational interventions at improving atopic dermatitis severity: A systematic review. Dermatitis. 2021. In Press.
81. Luger TA, Hebert AA, Zaenglein AL, Silverberg JI, Tan H, Ports WC, Zielinski MA. Subgroup analysis of crisaborole for mild-to-moderate atopic dermatitis in children aged 2 to <18 years. Pediatric Drugs. 2022. 24(2): 175-183.
82. Atwater AR, Bembry R, Liu B, Warshaw EM, DeKoven JG, Silverberg JI, Taylor JS, Zug KA, Houle M, Belsito DV, Maibach HI, Reeder MJ, Sasseville D, Dunnick C, Fowler JF, Pratt MD, DeLeo VA. Medical Adhesive Allergens: Retrospective Analysis of Cross- Sectional Data from the North American Contact Dermatitis Group, 2001-2018. Journal of the American Academy of Dermatology. 2021 Dec 5:S0190-9622(21)02927-3. doi: 10.1016/j.jaad.2021.11.055. Online ahead of print.
83. Warshaw EM, Buonomo M, DeKoven JG, Pratt MD, Reeder MJ, Silverberg JI, Belsito DV, Maibach HI, Atwater AR, Houle MC, Taylor JS, Zug KA, DeLeo VA, Dunnick CA. Importance of Supplemental Patch Testing Beyond a Screening Series for Patients With Dermatitis: The North American Contact Dermatitis Group Experience. JAMA Dermatology. 2021. 157(12): 1456-1465.
84. Narla S, Silverberg JI. Dermatology for the internist: optimal diagnosis and management of atopic dermatitis. Annals of Internal Medicine. 2021. 53(1):2165-2177.
85. Rakita U, Kaundinya T, Guraya A, Nelson K, Maner B, Manjunath J, Schwartzman G, Lane B, Silverberg JI. Lack of association between seborrheic dermatitis and SARS-CoV-2 outcomes. Journal of the European Academy of Dermatology and Venereology. 2022. 36(3): e177-e179.
86. Off-Label Uses of JAK Inhibitors in Dermatology Nussbaum D, McCormick E, Desai S, Murphy E, Saardi K, Friedman A, Journal of Drugs in Dermatology. 2022 Oct 25
87. "Knife-cut" intertriginous ulcers related to herpes simplex virus in three patients: Millan S, Ali R, Sanfilippo E, Siegel M, Cardis MA, Saardi KM. Dermatol Online J. 2022 Aug 15;28(4).
88. An Up-to-Date Approach to the Management of Dissecting Cellulitis: Nussbaum D, Desai S, Nelson K, Saardi K, Friedman A. J Drugs Dermatol. 2022 Jul 1;21(7):800-802
89. Erythematous Papules on the Ears. Zachary CMB, Bajoghli AA, Hernandez G, Kemprecos H, Saardi KM, Cardis MA. Cutis. 2022 Jul;110(1):7-20
90. Monkeypox Virus-Associated Severe Proctitis Treated With Oral Tecovirimat: A Report of Two Cases. Lucar J, Roberts A, Saardi KM, Yee R, Siegel MO, Palmore TN. Ann Intern Med. 2022 Aug 18.
91. A dialysis patient with subungual hyperkeratosis and ulceration of the fingertips. Millan SH, Saardi KM, Nadimi AE, Norton SA. JAAD Case Rep. 2022;22:5-7.
92. Blisters in a comatose elderly woman. Kurtyka DJ, Saardi KM, Cardis MA. Cutis. 2022;109(1):E24.
93. Calciphylaxis: Part I. Diagnosis and pathology. Rick J, Strowd L, Pasieka HB, Saardi KM et al. J Am Acad Dermatol. 2022;86(5):973-982.
94.Bukstein DA, Friedman A, Gonzalez Reyes E, Hart M, Jones BL, Winders T. Impact of Social Determinants on the Burden of Asthma and Eczema: Results from a US Patient Survey. Adv Ther. 2022 Jan 24. doi: 10.1007/s12325-021-02021-0.
95.Adusumilli NC, Friedman AJ. Benign Familial Pemphigus. JAMA Dermatol. 2022 Jan 12. doi: 10.1001/jamadermatol.2021.5177. 221.Wei C, Adusumilli N, Friedman A, Patel V. Perceptions of Artificial Intelligence Integration into Dermatology Clinical Practice: A Cross-Sectional Survey Study. J Drugs Dermatol. 2022 1;21(2):135-140.
96.Manjunath J, Friedman A. Assessing Dermatology Provider Perceptions and Attitudes About the Unique Needs of Older Adult Patients. J Drugs Dermatol. 2022 1;21(3):331-332.
97.Nussbaum D, Glass L, Friedman A. mTOR Inhibitor-Induced Transient Acantholytic Dermatitis. J Drugs Dermatol. 2022 1;21(3):315-316. 224.Whiting C, Duan X, Friedman A. Evaluation of Cannabis and Cannabinoid Product Use, Knowledge, and Attitudes in the Eczema Community. J Drugs Dermatol. 2022;21(4):413-419.
98.Nussbaum D, Kalen J, Zahn J, Friedman A. Offering an Off-Label Therapeutic Algorithm for Lichen Planus J Drugs Dermatol. 2022;21(4):444-446.
99.Nussbaum D, Wei C, Pakhchanian H, Raiker R, Liu IZ, Friedman A. Reduction in new pityriasis rosea diagnoses during the COVID-19 pandemic: Evidence in support of a viral etiology. JAAD Int. 2022;7:124-125.
100.Adusumilli N, Shoen E, Friedman A. Psychosocial Burden of Verruca Vulgaris: A Cross-Sectional Survey. J Drugs Dermatol. 2022 Jun 1;21(6):614-617.
101.Venkatesh K, Brito G, Nelson K, Friedman A. Barriers to Care-Seeking and Treatment Adherence Among Dermatology Patients: A Cross-Sectional National Survey Study. J Drugs Dermatol. 2022 Jun 1;21(6):677-680.
102.Greenzaid J, Friedman A, Sodha P. The Use of Bakuchiol in Dermatology: A Review of In Vitro and In Vivo Evidence. J Drugs Dermatol. 2022 Jun 1;21(6):624- 629.
103.Nussbaum D, Desai S, Nelson K, Saardi K, Friedman A. An Up-to-Date Approach to the Management of Dissecting Cellulitis. J Drugs Dermatol. 2022. 1;21(7):800-802.
104.Nussbaum D, Desai S, Gonzalez-Lopez A, Hawkes JE, Gondo G, Friedman A. Practices and perspectives on medical cannabis and cannabinoids: A survey of the National Psoriasis Foundation Medical Advisory Board. JAAD Int. 2022. 19;9:23-25.
105.Venkatesh K, Brito G, Nelson K, Friedman A. Nontraditional Healing Utilization and Disclosure Among Dermatology Patients: A National Cross-Sectional Survey Study. J Drugs Dermatol. 2022.n1;21(9):1015-1018.
106.Nussbaum D, Murphy E, Nelson K, Gonzalez-Lopez A, Qureshi A, Schwartz J, Friedman A. A Survey of Patient Attitudes Towards Topical Minoxidil in the Treatment of Hair Loss. J Drugs Dermatol. 2022. 1;21(10):1140-1142.
107.Nussbaum D, Wei C, Pakhchanian H, Raiker R, Liu IZ, Friedman A. Reply to 'Pityriasis rosea during COVID-19 and its pathogenesis' JAAD Int. 2022 Sep 27. doi: 10.1016/j.jdin.2022.05.014. Online ahead of print.
108.Veerabagu SA, Trinklein R, Etzkorn JR, Leung T, Miller DC, Rosman IS, Friedman A. The National Mentorship Match Algorithm: A New Approach to Filling Mentorship Gaps. J Am Acad Dermatol. 2022. 7:S0190-9622(22)02982-6.
109.Adusumilli N, Aronica J, Glass F, Friedman A. Concurrent Interstitial Granulomatous Dermatitis and TNF-α Antagonist-Induced Lupus Syndrome Secondary to Adalimumab for Crohn's Disease. J Drugs Dermatol. 2022. 1;21(11):1256-1257.
110.Desai S, McCormick E, Friedman A. An Up-to-Date Approach to the Management of Seborrheic Dermatitis. J Drugs Dermatol. 2022.1;21(12):1373-1374.
111. Patel A, Guo E, Sodha P, Friedman PM. Laser Education in Dermatology Residency: Outcomes of a Resident- Reported Survey. Dermatol Surg. 2022;48(10):1129-1131.
112. Greenzaid J, Friedman A, Sodha P. The Use of Bakuchiol in Dermatology: A Review of In Vitro and In Vivo Evidence. J Drugs Dermatol. 2022;21(6):624-629.
113. Friedman PM, Dover JS, Chapas A, Rahman Z, Ross EV, Kilmer SL, Roberts WE, Sodha P, Stimmel JB, Moncrief MBC, Waibel JS. 1550 nm Erbium-Doped and 1927-nm Thulium Nonablative Fractional Laser System: Best Practices and Treatment Setting Recommendations. Dermatol Surg. 2022;48(2):195-200.
114. Sodha P, Wang JV, Friedman PM. Acoustic Shockwave Therapy as an Adjunct to Picosecond Laser for Multicolored Tattoo Removal. Dermatol Surg. 2022;48(1):153-155.
115. Algarin YA, Jambusaria A, Ruiz ES, Patel VA. Advances in Topical Treatments of Cutaneous Malignancies. American Journal of Clinical Dermatology. November 2022.
116. Algarin YA, McCullum C, Patel VA. Skin Cancer Screening Practices Among Dermatologists: A Survey Study. Journal of Drugs and Dermatology. November 2022.
117. Gross ND, Miller DM, Patel VA, et al. Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma. New England Journal of Medicine. 10.1056/NEJMoa2209813. September 2022
118. Algarin YA, Singer HM, Patel VA. Reconstruction of the Nasal Ala After Failure of an Interpolated Cheek-to-Nose Flap. Derm Surgery Aug 2022
119. Miller DM, Shalhout SZ, Saqlain F, Patel VA, Tsai KY, Elayavilli RK, Louv B, Brownell I, Wong MK. The Merkel Cell Carcinoma Patient Registry: From Promise to Prototype to Patient. Journal of Registry Management 2021 Volume 49 Number 1.
120. Wei C, Adusumilli NC, Friedman AJ, Patel VA. Perceptions of Artificial Intelligence Integration into Dermatology Clinical Practice: A Cross-Sectional Survey Study. JDD February 2022
121. Patel VA, McCullum C, Sparks AD, Schmults CD, Arron ST, AJambusaria-Pahlajani A. Cutaneous squamous cell carcinoma staging may influence management in users: A survey study. Cancer Medicine.
2021
1. Garcia A, Nelson K, Patel V. Emerging Therapies for Rare Cutaneous Cancers: A Systematic Review. Cancer Treatment Reviews. 2021 Aug 16;100:102266.
2. Konda S, Patel VA. Repair of an Extensive Central Chest Defect. Dermatol Surg. 2021 Aug 1;47(8):1103-1105.
3. Hughes ME, Aralis H, Bruhn, KW, Cotliar J, Craft N, DeLuca IJ, Hamidi R, Nguyen K, Patel M, Patel VA, Sofen H, Tan B, David CV. A Reliability Study Using Network-Oriented Research Assistant (NORA®) to Evaluate the Use of Digital Photographs in the Assessment of Atopic Dermatitis. J Am Acad Dermatol. 2021 Sep;85(3):725-726
4. Wei C, Quan T, Wu T, Gu A, Chan S, Chien JL, Patel VA, Friedman AJ. Assessment of the accessibility and content of dermatology fellowship websites. J Am Acad Dermatol. 2021 May;84(5):1423-1425.
5. Orseth ML, Black WH, Neal D, Golda N, Patel VA, Etzkorn JR. Patients Value Low Local Recurrence Rates and Prevention of Re-excisions With High-Risk Tumors. Dermatol Surg. 2021 Mar 1;47(3):410-412.
6. Wei C, Allais B, Tornberg HN, Quan T, Adusumilli NC, Patel VA, Friedman AJ. The utilization of the Altmetric and PlumX scores in evaluating the top 100 trending melanoma articles in social media. Journal of the American Academy of Dermatology. 2021 Jan 8;S0190-9622
7. Donigan JM, Srivastava D, Maher I, Abdelmalek M, Bar AA, Blalock TW, Bordeaux JS, Brodland DG, Carroll BT, Council ML, Duffy K, Fathi R, Golda N, Johnson-Jahangir H, Konda S, Leitenberger JJ, Moye M, Nelson JL, Patel VA, Shaffer JJ, Soltani-Arabshahi R, Tristani-Firouzi P, Tschetter AJ, Nijhawan RI. Opioid Prescribing Recommendations After Mohs Micrographic Surgery and Reconstruction: A Delphi Consensus. Dermatologic Surgery. 2021 Feb 1;47(2):167-169.
8. Sodha P, Richmond H, Friedman PM. Safe and effective use of a novel large spot size 595-nm pulsed dye laser with high energies for rapid improvement of adult and pediatric port wine stains. Dermatol Surg. 2021;47(8):1147- 1149.
9. Sodha P, Suggs A, Munavalli GS, Friedman PM. A Randomized Controlled Pilot Study: Combined 595-nm Pulsed Dye Laser Treatment and Oxymetazoline Hydrochloride Topical Cream Superior to Oxymetazoline Hydrochloride Cream for Erythematotelangiectatic Rosacea. Lasers Surg Med. 2021;53(10):1307-1315.
10. Sodha P, Friedman PM. Commentary on Clinical Evaluation of Safety and Efficacy of 670-nm Picosecond Laser for treatment of Benign Pigmented Lesions in Asians. Dermatol Surg. 2021;47(5): 635-36.
11. Wang JV, Noell C, Sodha P, Albornoz CA, Friedman PM, Zachary CB, Saedi N. Comparing medical spas and physician practices for cosmetic procedures: A survey of millennial consumers. Dermatol Surg.2021;47(7):1042-1044
12.Adusumilli NC, Hausmann K, Friedman AJ, Maiberger M. Leveraging Virtual Boot Camp to Alleviate First Year Dermatology Resident Anxiety. J Drugs Dermatol. 2021.1;20(1):112-113. doi: 10.36849/JDD.2021.5574.
13.Ma Wei C, Hazuka E, DeRosa P, Paulson JM, Friedman AJ. Pyoderma Gangrenosum Occurring in the Setting of Hypercortisolism Associated With Adrenocortical Adenoma: A Pathophysiological Parado. J Drugs Dermatol. 2021 1;20(1):95-97. doi: 10.36849/JDD.2021.5566.
14.Mays DA, Friedman AJ, Kennedy J, Yiannias JA, Morgan JA. Undisclosed Fragrance Allergens in Clean Cosmetic Cleansers Place Patients at Risk. Dermatitis. 2021 Jan 11. doi: 10.1097/DER.0000000000000604. Online ahead of print.
15.Adusumilli NC, Mordorski B, Nosanchuk J, Friedman JM, Friedman AJ. Curcumin nanoparticles as a photoprotective adjuvant. Exp Dermatol. 2021 Jan 15. doi: 10.1111/exd.14282. Online ahead of print.
16.Yeroushalmi S, Millan SH, Nelson K, Sparks A, Friedman AJ. Patient Perceptions and Satisfaction With Teledermatology During the COVID-19 Pandemic: A Survey- Based Study. J Drugs Dermatol. 2021 1;20(2):178-183. doi: 10.36849/JDD.2021.5714.
17.Shoen E, Hou A, Zahn J, Friedman A. Successful Treatment of Lichen Amyloidosis Using a Fixed Combination of Halobetasol-Propionate and Tazarotene Lotion. J Drugs Dermatol. 2021;20(3):336-337
18.Adusumilli NC, Friedman AJ. An Updated Therapeutic Strategy for Chronic Idiopathic Urticaria. J Drugs Dermatol. 2021; 20(3):354-355.
19.Stamatas GN, Bensaci J, Greugny E, Kaur S, Wang H, Dizon MV, Cork MJ, Friedman AJ, Oddos T. A predictive self-organizing multicellular computational model of infant skin permeability to topically applied substances. J Invest Dermatol. 2021;8:S0022-202X(21)00236-0.
20.Schwartzman G, Qureshi A, Friedman AJ. Utilization of Instagram by dermatology residency programs in the era of COVID-19. J Am Acad Dermatol. 2021 Mar 31:S0190-9622(21)00638-1.
21.Schwartzman G, Qureshi A, Friedman AJ. Response to letter: Utilization of Instagram by dermatology residency programs in the era of COVID-19. J Am Acad Dermatol. S0190-9622(21)02222-2.
22.Yu Z, Jia JL, Veerabagu SA, Burkemper NM, Friedman AJ, Rosmarin D, Huang JT, Murina AT, Nord KM. Supporting Underrepresented in Medicine (UIM) and non-UIM Trainees Applying into Dermatology: A Qualitative Analysis. J Drugs Dermatol. 2021;20(7):795-797.
23.Shah N, Kirkorian AY, Friedman AJ. Evaluating provider knowledge, perception, and concerns about cannabinoid use in pediatric dermatology. Pediatr Dermatol. 2021;38(3):694-696.
24.Costa-Orlandi CB, Martinez LR, Bila NM, Friedman JM, Friedman AJ, Mendes- Giannini MJS, Nosanchuk JD. Nitric Oxide-Releasing Nanoparticles Are Similar to Efinaconazole in Their Capacity to Eradicate Trichophyton rubrum Biofilms. Front Cell Infect Microbiol. 2021 Jul 15;11:68415.
25.Wei C, Fong A, Quan T, Gupta P, Friedman AJ. (2020). Assessment of Altmetric and PlumX metrics scoring as mechanisms to evaluate the top 100 Trending Hidradenitis Suppurativa information on social media: A cross-sectional analysis. Journal of Medical Internet Research Dermatology. 3(1): e23724.
26.Adusumilli NC, Friedman AJ Treating Cutaneous Immune-Related Adverse Events from Immune Checkpoint Blockade. J Drugs Dermatol. 2021;1;20(10):1133-1134.
27.Jia JL, Yu Z, Veerabagu SA, Burkemper NM, Friedman AJ, Rosmarin D, Huang JT, Murina AT, Nord KM. Improving information transparency between dermatology residency programs and trainees: Report from the Association of Professors of Dermatology Work Group on Transparency J Am Acad Dermatol. 2021;85(5):1293- 1296.
29. Covid-19-the American perspective. Saardi K, Petronic-Rosic V. Clin Dermatol. 2021;39(3):424-429.
2020
1. Golda N, Black W, Patel V, Neal D, Etzkorn J. How Patients Value Scar Length Versus Scar Appearance and the Effect of Income Level on Willingness to Pay: Results From a Multicenter Discrete Choice Experiment. Dermatologic Surgery 2020 Oct;46(10):1347-1350
2. Neal DE, Golda N, Patel V, Black W, Lee MP, Etzkorn JR. Local Anesthesia Is Preferred for Skin Cancer Surgery-Results of a Choice-Based Conjoint Analysis Experiment. Dermatol Surg. 2020 Aug;46(8):1106-1108.
3. Teixeira JC, Patel V, Goodman J. Multifocal Recurrent Microcystic Adnexal Carcinoma. J Craniofac Surg. 2020 May 8.
4. Friedman PM, Polder KD, Sodha P, Geronemus RG. The 1440 nm and 1927 nm Nonablative Fractional Diode Laser: Current Trends and Future Directions. J Drugs Dermatol. 2020;19(8):s3-11.
5.Murphy EC, Friedman AJ. Hydrogen Peroxide Topical Solution, 40% (w/w) for the Treatment of Seborrheic Keratoses: A Review. Skin Therapy Lett. 2020;25(1):1-4.
6.Wei C, Friedman AJ, Prussick RB. Psoriasis improvement and satisfaction in patients utilizing a clobetasol spray and oral apremilast combination regimen- a pilot study. J Am Acad Dermatol. 2020 Feb 20. pii: S0190-9622(20)30275-9.
7.Murphy EC, Alptunaer T, Noll S, Phillips J, Friedman AJ. Survey of Dermatologists’ Preparedness for Natural and Manmade Disasters J Drugs Dermatol. 2020 Feb 1;19(2):195-197.
8.Mays, David A, Friedman A, Kennedy J, Yiannias J, Morgan J.Petroleum Ingredients Detected in Cleansers Claiming to be Natural and Petrochemical Free. J Am Acad Dermatol. 2020. doi.org/10.1016/j.jaad.2020.04.127
9.Yeroushalmi S, Shirazi JY, Friedman A. New Developments in Bacterial, Viral, and Fungal Cutaneous Infections. Curr Dermatol Rep. 2020;9(2):152-165.
10.Wei C, Bovonratwet P, Gu A, Moawad G, Sculco PK, Silverberg JI, Friedman AJ. Spironolactone Use Does Not Increase the Risk of Female Breast Cancer Recurrence: A Retrospective Analysis. J Am Acad Dermatol. 2020 21:S0190- 9622(20)30950-6.
11.Aizman L, Nelson K, Sparks AD, Friedman AJ. The Influence of Supportive Oncodermatology Interventions on Patient Quality of Life: A Cross-Sectional Survey. J Drugs Dermatol. 2020;19(5):477-482.
12.Wei C, Friedman AJ. COVID-19 Pandemic: Are There Unique Cutaneous Manifestations in Patients Infected With SARS-CoV-2? J Drugs Dermatol. 2020;19(5):554-555.
13.Murphy EC, Nelson K, Friedman AJ. The Influence of Dermatologists' Use of Social Media on Attracting Patients. J Drugs Dermatol. 2020;19(5):532-538.
14.Wei C, Quan T, Wu T, Gu A, Chan S, Chien JL, Patel VA, Friedman AJ. Assessment of the Accessibility and Content of Dermatology Fellowship Websites. J Am Acad Dermatol. 2020 9:S0190-9622(20)31077-X.
15.Wei C, Eleryan MG, Gu A, Friedman AJ. Assessing a Paradigm Shift: Perceptions of the USMLE Step 1 Scoring Change to Pass/Fail. J Drugs Dermatol. 2020; 19(6):669-671.
16.Yeroushalmi S, Nelson K, Sparks A, Friedman A. Perceptions and recommendation behaviors of dermatologists for medical cannabis: A pilot survey. Complement Ther Med. 2020;55:102552.
17.Draelos ZD, Rigel D, Friedman A. Development of a Photonumeric Lip Health Scale. J Drugs Dermatol. 2020;19(6):632-636.
18.Gorelick J and Friedman A. Diagnosis and Management of Primary Hyperhidrosis: Practical Guidance and Current Therapy Update.J Drugs Dermatol. 2020; 19(7):704-710.
19.Arnold JA, Yoon SJ, Friedman A. Disparities in the Utilization of Dermatologists for Primary Cicatricial Alopecias. J Drugs Dermatol. 2020;19(7): 784-785.
20.Adusumilli NC, Zhang D, Friedman JM, Friedman AJ. Harnessing nitric oxide for preventing, limiting and treating the severe pulmonary consequences of COVID-19. Nitric Oxide. 2020; 15;103:4-8.
21.Friedman AJ, Momeni K, Kogan M. Topical Cannabinoids for the Management of Psoriasis Vulgaris: Report of a Case and Review of the Literature J Drugs Dermatol. 2020;19(8):795.
22.Jia JL, Yu Z, Veerabagu SA, Burkemper NM, Friedman AJ, Rosmarin D, Huang JT, Murina AT, Nord KM. Improving Information Transparency Between Dermatology Residency Programs and Trainees: Report from the Association of Professors of Dermatology Work Group on Transparency. J Am Acad Dermatol. 2020: S0190- 9622(20)32539-1.
23.Williams AT , Muller CR, Govender K, Navati MS, Friedman AJ, Friedman JM, Cabrales P. Control of systemic inflammation through early nitric oxide supplementationwith nitric oxide releasing nanoparticles. Free Radical Biology and Medicine, https://doi.org/10.1016/j.freeradbiomed.2020.09.025.
24.Venkatesh KP, Nelson K, Friedman A. Sociocultural attitudes and perceptions of potential barriers to care for dermatology patients. J Am Acad Dermatol. 2020:S0190-9622(20)32620-7.
25.Wei C, Murphy EC, Zahn J, Friedman AJ. Is TNF-α Inhibitor-Induced Psoriasiform Dermatitis Always Psoriasiform? J Drugs Dermatol. 2020. 1;19(10):1009-1010.
26.Allais B, Friedman A Colloidal Oatmeal Part I: History, Basic Science, Mechanism of Action, and Clinical Efficacy in the Treatment of Atopic Dermatitis. J Drugs Dermatol. 2020.1;19(10):s4-s7.
27.Allais B, Friedman A. Colloidal Oatmeal Part II: Atopic Dermatitis in Special Populations and Clinical Efficacy and Tolerance Beyond Eczema. J Drugs Dermatol. 2020.1;19(10):s8-s11.
28.Rosmarin D, Friedman AJ, Burkemper NM, Nord KM, Murina AT, Huang JT.The Association of Professors of Dermatology Program Directors Task Force and Residency Program Transparency Work Group Guidelines on Residency Program Transparency. J Drugs Dermatol. 2020; 19(11):1117-1118.
29.Wei C, Allais B, Tornberg HN, Quan T, Adusumilli NC, Patel VA, Friedman AJ. The utilization of the Altmetric and PlumX scores in evaluating the top 100 trending melanoma articles in social media. J Am Acad Dermatol. 2021 Jan 8;S0190- 9622(21)00084-0.doi: 10.1016/j.jaad.2020.12.067.
30. A female with subcutaneous nodules and livedo racemosa. Bell KA, Saardi K, Alejandro P, Boger L. JAAD Case Rep. 2020;6(12):1313-1315.
31. Atypical presentation of pearly penile papules. Saardi KM, Dubin JM, Cardis MA. Can Urol Assoc J. 2020 Oct 27.
32. Alemtuzumab as Initial Therapy for Sézary Syndrome: A Report of Two Cases Brumfiel CM, Saardi KM, Ronkainen SD, Shenoy AG JAAD Case Reports, In Press 7/11/2020
33. Use of Psoralen Therapies Obtained Abroad in Two Children with Vitiligo Bell KA, Saardi KM, Norton SA, Habeshian KA Pediatric Dermatology, Accepted for publication 6/21/2020
34. Calcinosis Cutis in the Setting of Chronic Skin Graft-Versus-Host Disease Saardi KM, Rosenstein RK, Anadkat MJ, Micheletti RG, Schiffenbauer AI, Pavletic SZ, Cowen EW JAMA Dermatology, May 2020
35. Acquired Ichthyosis in a Middle-Aged Woman Saardi KM, DeWitt CA, Cardis MA JAMA Dermatology, May 2020
36. The Case of Missing Skin: Congenital Volkmann Ischemic Contracture Coerdt KM, Guo EL, Saardi KM, Habeshian KA Pediatric Dermatology, April 2020
37. Dermatomyositis: Clinical Features and Pathogenesis [letter] Saardi KM, Zachary CM, DeWitt CA, Cardis MA Journal of the American Academy of Dermatology, July 2020
2019
1. Crow LD, Jambusaria-Pahlajani A... Patel VA,...Arron ST. Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines. Transplant international : official journal of the European Society for Organ Transplantation. 2019 Dec. 32, 1268-1276.
2. Golda N, Black W, Patel V, Neal D, Etzkorn J. Determining patient preferences and willingness to pay related to scar length and appearance after skin cancer treatment on the face and trunk: A multicenter discrete choice experiment. J Am Acad Dermatol. 2019 Oct;81(4):1011-1013.
3. Jeong D, Aralis H, Bruhn KW, Cotliar J, Craft N, DeLuca IJ, Hamidi R, Nguyen K, Patel VA, Sofen H, Tan BH, David CV. A Reliability Study Using Network Oriented Research Assistant (NORA®) Examining the Use of Digital Photographs in the Assessment of Psoriasis. Br J Dermatol. 2019 Jul;181(1):214-215.
4. Vance S, Fontecilla N, Samie FH, Patel V, Lewin JM. Effect of Postoperative Telephone Calls on Patient Satisfaction and Scar Satisfaction After Mohs Micrographic Surgery. Dermatol Surg. 2019 Mar 19.
5. Leung N, Eldek H, Ramirez M, Sodha P. Erosive pustular dermatosis of the scalp: successful treatment with oral tofacitinib. JAMA Dermatology. 2019;155(6): 752-754.
6. Qureshi AA, Friedman AJ. A Review of the Dermatologic Symptoms of Idiopathic Mast Cell Activation Syndrome. J Drugs Dermatol. 2019;18(2):162-168.
7. Bhatia N, Friedman A, Del Rosso J. Applications of Topical Oak Bark Extract in Dermatology: Clinical Examples and Discussion J Drugs Dermatol. 2019;18(2):203-206.
8.Nussbaum D and Friedman A. Pseudofolliculitis Barbae: A Review of Current Treatment Options. J Drugs Dermatol. 2019;18(3):246-250.
9.Murphy E, Nussbaum D, Prussik R, Friedman A. Use of complementary and alternative medicine by patients with psoriasis. J Am Acad Dermatol. 2019;81(1):280-283.
10.Murphy E, Friedman AJ. Hydrogen peroxide and cutaneous biology: Translational applications, benefits, and risks. J Am Acad Dermatol. 2019 May 16. pii: S0190- 9622(19)30797-2.
11.Murphy EC, Kao S, Wang H, Nguyen H, Friedman AJ. A Survey-Based Comparison of Sun Safety Practices in a Representative Cohort of the General Public Versus Attendees of a Skin Cancer Screening. J Drugs Dermatol. 2019;18(7):649-653.
12.Qureshi A, Murphy E, Milando R, Rengifo-Pardo M, Clayton C, Friedman A. A Head-to-Head Comparison of Topical Collagen Powder to Primary Closure for Acute Full-Thickness Punch Biopsy-Induced Human Wounds: An Internally Controlled Pilot Study. J Drugs Dermatol. 2019;18(7):667-673.
13.Nussbaum D, Schwartz J, Friedman A. A Giant Cutaneous Horn: One of the Largest Recorded. J Drugs Dermatol. 2019;18(7):697-698.
14.Murphy EC, Friedman AJ. Use of In-Office Preparations by Dermatologists for the Diagnosis of Cutaneous Fungal Infections. J Drugs Dermatol. 2019; 18(8):798-802.
15.Murphy EC, Nussbaum D, Prussick R, Friedman AJ. Reply to: "Response to: 'Use of complementary and alternative medicine by patients with psoriasis'". J Am Acad Dermatol. 2019 Jun 13. pii: S0190-9622(19)30972-7.
16. Recommendations for Prevention of Drug Re-Exposure in Toxic Epidermal Necrolysis O’Brien KF, Saardi KM, Johnson LS, Shupp JW, Rodic N, Pasieka HB Journal of Drugs in Dermatology, Oct 2019
2018
1. Singer HM, Patel VA. Forehead Reconstruction After Resection of Squamous Cell Carcinoma. Dermatol Surg. 2018 Jul;44(7):1018-1022.
2. Singer HM, Almazan T, Craft N, David CV, Eell S, Erfe C, Lazzaro C, Nguyen K, Preciado K, Tan B, Patel VA. Use of the Network Oriented Research Assistant technology to validate the use of digital photographs in the assessment and quantification of acne vulgaris. JAMA Dermatology 2018 Feb 1;154(2):188-190
3. Konda S, Jospeh F, Patel VA. Letter to editor: Effectiveness of the Mohs and close technique in increasing the efficiency of a Mohs micrographic surgery. Journal of Drugs in Dermatology 2017 Dec 1;16(12):1301-1302.
4. Garrett GL, Yuan JT, Shin TM, Arron ST on behalf of Garrett GL, Colegio OR, Curiel-Lewandrowski C, Griffin JR, Huang CC, Jambusaria A, Jiang SI, Leitenberger Nijhawan RI, Ochoa S, Olasz EB, Patel VA, Pugliano-Mauro M, Schmults CD, Schram S, Shih AF, Shin T, Soon S, Soriano T, Srivastava D, Stein JA, Sternhell-Blackwell K, Taylor S, Vidimos A, Wu P, Arron ST. Validity of skin cancer malignancy reporting to the Organ Procurement Transplant Network: A cohort study. J Am Acad Dermatol. 2018 Feb;78(2):264-269.
5. Kraus C, Sodha P, Vaidyanathan P, Kirkorian AY. Thyroid Dermopathy and Acropachy in Pediatric Patients. Pediatric Dermatology. 2018;35(6):e371-e374.
6. Kraus C, Sodha P, Kirkorian AY. A Child with a Blistering Rash.JAMA Pediatrics. 2018;172: 592-593.
7. Kallis PJ, Friedman AJ, Lev-Tov H. A Guide to Tissue-Engineered Skin Substitutes. J Drugs Dermatol. 2018 Jan 1;17(1):57-64.
8.Kao S, Yadgar R, Enlow T, Friedman A. Blastomycosis-like Pyoderma arising in Lichen Planus. J Drugs Dermatol. 2018 1;17(2):233-235.
9.Ranasinghe G and Friedman A. Eruptive sebaceous hyperplasia: a rare consequence of systemic corticosteroids. J Drugs Dermatol. 2018 1;17(1):118-120.
10.Kallis PJ, Friedman AJ. Collagen Powder in Wound Healing. J Drugs Dermatol. 2018:1;17(4):403-408.
11.Kao S, Kiss A, Efimova T, Friedman A. An ex-vivo evaluation of cytotoxicity and melanocyte viability after A-101 hydrogen peroxide topical solution 40% or cryosurgery treatment in Seborrheic Keratosis lesions. J Am Acad Dermatol. 2018 Mar 27. pii: S0190-9622(18)30488-2. doi: 10.1016/j.jaad.2018.03.034. [Epub ahead of print]
12.Qureshi AA, Friedman AJ. Complex Regional Pain Syndrome: What the Dermatologist Should Know. J Drugs Dermatol. 2018;17(5):532-536
13.Costa-Orlandi CB, Mordorski B, Baltazar LM, Mendes-Giannini MJS, Friedman JM, Nosanchuk JD, Friedman AJ. Nitric Oxide Releasing Nanoparticles as a Strategy to Improve Current Onychomycosis Treatments. J Drugs Dermatol. 2018;17(7):717-720.
14.Kao S, Kiss A, Efimova T, Friedman AJ. Managing Seborrheic Keratosis: Evolving Strategies and Optimal Therapeutic Outcomes. J Drugs Dermatol. 2018 1;17(9):933- 940.
15.Qureshi A, Abate L, Yosipovitch P, Friedman A. A Systematic Review of Evidence- Based Treatments for Prurigo Nodularis. J Am Acad Dermatol https://doi.org/10.1016/j.jaad.2018.09.020
17.Krausz AE, Adler BL, Makdisi J, Schairer D, Rosen J, Landriscina A, Navati M, Alfieri A, Friedman JM, Nosanchuk JD, Rodriguez-Gabin A, Ye KQ, McDaid HM, Friedman AJ. Nanoparticle-Encapsulated Doxorubicin Demonstrates Superior Tumor Cell Kill in Triple-Negative Breast Cancer Subtypes Intrinsically Resistant to Doxorubicin. Prec. Nanomed. 2018;1(3):172-185.
18.Marks DH, Qureshi A, Friedman A. Evaluation of Prevention Interventions for Taxane-Induced Dermatologic Adverse Events: A Systematic Review. JAMA Dermatol. Published online October 31, 2018. doi:10.1001/jamadermatol.2018.3465
19.Kao S and Friedman A. Supportive Oncodermatology: Addressing dermatologic adverse events associated with oncologic therapies. Oncology Issues. 2018; 33(6): 64-75.
20.Marks D and Friedman A. The Therapeutic Potential of Cannabinoids in Dermatology. Skin Therapy Letters. 2018; 23(6): 1-6
22.Milando R. and Friedman A. Cannabinoids: Potential Role in Inflammatory and Neoplastic Skin Diseases. Am J Clin Dermatol. 2018: https://doi.org/10.1007/s40257-018-0410-5.
23.Robinson E, Murphy E, and Friedman A. Knowledge, Attitudes, and Perceptions of Cannabinoids in the Dermatology Community. J Drugs Dermatol. 2018;17(12):1273- 1278.
2017
1. Garrett GL, Blanc PD, Boscardin J, Lloyd AA, Ahmed RL, Anthony T, Bibee K, Breithaupt A, Cannon J, Chen A, Cheng JY, Chiesa-Fuxench Z, Colegio OR, Curiel-Lewandrowski C, Del Guzzo CA, Disse M, Dowd M, Eilers R Jr, Ortiz AE, Morris C, Golden SK, Graves MS, Griffin JR, Hopkins RS, Huang CC, Bae GH, Jambusaria A, Jennings TA, Jiang SI, Karia PS, Khetarpal S, Kim C, Klintmalm G, Konicke K, Koyfman SA, Lam C, Lee P, Leitenberger JJ, Loh T, Lowenstein S, Madankumar R, Moreau JF, Nijhawan RI, Ochoa S, Olasz EB, Otchere E, Otley C, Oulton J, Patel PH, Patel VA, Prabhu AV, Pugliano-Mauro M, Schmults CD, Schram S, Shih AF, Shin T, Soon S, Soriano T, Srivastava D, Stein JA, Sternhell-Blackwell K, Taylor S, Vidimos A, Wu P, Zajdel N, Zelac D, Arron ST. Incidence of and Risk Factors for Skin Cancer in Organ Transplant Recipients in the United States. JAMA Dermatol. 2017 Mar 1;153(3):296-303.
2. Patel VA, Colegio O, Leitenberger JJ, Arron ST. Complex cases in transplant dermatology Presented by the Transplant Skin Cancer Network. JAAD Case Reports Volume 1, Issue 6, Supplement 1, Pages A1-A4, S1-S40
3..Seite S, del Marmol V, Moyal D. and Friedman A. Public primary and secondary skin cancer prevention, perceptions and knowledge: An international cross-sectional survey. J Eur Acad Dermatol Venereol. 2017 Jan 3. doi: 10.1111/jdv.14104. [Epub ahead of print]
4.Baldwin HE, Bhatia N, Friedman A, Eng RM, Seite S. The Role of Cutaneous Microbiota Harmony in Maintaining a Functional Skin Barrier. J Drugs Dermatol. 2017;16(1):12-18.
5.Yadgar RJ, Bhatia N, Friedman A. Cutaneous fungal infections are commonly misdiagnosed: A survey-based study. 2017 Mar;76(3):562-563.
6.Totorailis K, Cohen J, Friedman A. Topical Approaches to Improve Surgical Outcomes and Wound Healing: A Review of Safety and Efficacy. J Drugs Dermatol. 2017; 16(3): 209-212.
7.Oliver B, Durrani S, Cohen J, Friedman A. Current Perspectives Among U.S. Dermatologists on Chemoprevention of Nonmelanoma Skin Cancer: A Survey-Based Study J Drugs Dermatol. 2017;16(5):449-452.
8.Lee T, Schwartz J, Friedman A. Senior Peer-to-Peer Case Studies. J Drugs Dermatol. 2017; 16(6): 628.
9.Mordorski B, Costa-Orlandi C, Baltazar LM, Carreño LJ,, Landriscina A, Rosen J, Navati M, Mendes-Giannini M, Friedman JM, Nosanchuk JD, Friedman AJ. Topical nitric oxide releasing nanoparticles are effective in a murine model of dermal Trichophyton rubrum dermatophytosis. Nanomedicine. 2017 Jul 13. pii: S1549- 9634(17)30127-2. doi: 10.1016/j.nano.2017.06.018. [Epub ahead of print]
10.Oliver B, Macri C, Friedman A. Genetics education in U.S. dermatology residency programs: a survey-based study. J Grad Med Educ. 2017;9(4):545-546.
11.Austin TO, Matamoros AJ, Friedman JM, Friedman AJ, Nacharaju P, Yu W, Sharp D, Baas D. Nanoparticle Delivery of Fidgetin siRNA as a Microtubule-based Therapy to Augment Nerve Regeneration. Scientific Reports. 2017; 7, Article number: 9675.
12.Totorailis K, Magro C, Friedman A. Serpiginous Purpuric Eruption of the Leg J Drugs Dermatol. 2017;16(10):611-613
13.Fleischer DM, Udkoff J, Borok J, Friedman A, Nicol N, Bienstock J, Lio P, Tollefson MM, Eichenfield LF. Atopic dermatitis: skin care and topical therapies. Semin Cutan Med Surg. 2017;36(3):104-110.
14.Ahluwalia J, Davis DM, Jacob S, Waldman A, Ong PY, Cohen S, Friedman A, Lio P, Jetter N, Bienstock J, LeBovidge J, Spergel J, Fonacier L. Atopic dermatitis: addressing allergy, infection, itch and complementary therapies. Semin Cutan Med Surg. 2017;36(3):112-117.
15.Ranasinghe G and Friedman A. Managing Seborrheic Keratoses: Evolving Strategies for Optimizing Patient Outcomes J Drugs Dermatol. 2017;16(11): 1064- 1068.
2016
1.Ahmadi M, Lee H, Sanchez D, Friedman A, Tar M, Davies K, Nosanchuk JD, and Martinez L. Sustained nitric oxide releasing nanoparticles induce cell death in Candida albicans yeast and hyphal cells preventing biofilm formation in vitro and in a rodent central venous catheter model. Antimicrob Agents Chemother. 2016. 25;60(4):2185-94.
2.Friedman A, Waite K, Brandt S, Meckfessel MH. Accelerated Onset of Action and Increased Tolerability in Treating Acne With a Fixed-Dose Combination Gel J Drugs Dermatol. 2016;15(2):231-236.
3.Landriscina A, Friedman AJ. Integrating lifestyle-focused approaches into psoriasis care: improving patient outcomes? Psoriasis: Targets and Therapy. 2016:6 1–5.
4.Rosen J, Landriscina A, Friedman AJ. Psoriasis associated Fatigue. Cutis. 2016; 97(2):125-32.
5.del Pilar Sosa Peña M, Gottipati A, Tahiliani S, Neu-Baker NM, Fram MD, Friedman AJ, Brenner S. Hyperspectral imaging of nanoparticles in biological samples: simultaneous visualization and elemental identification. Microsc Res Tech. 2016;79(5):349-58.
6.Krueger JG, Kircik L, Hougeir F, Friedman A, You X, Lucas N, Greenberg SJ, Sweetser M, Castro-Borrero W, McCroskery P, Elkins J. Cutaneous Adverse Events in the Randomized, Double-Blind, Active-Comparator DECIDE Study of Daclizumab High-Yield Process Versus Intramuscular Interferon Beta-1a in Relapsing-Remitting Multiple Sclerosis. Adv Ther. 2016;33(7):1231-45
7.Doerner J, Chalmers SA, Friedman A, Putterman C. Fn14 deficiency protects lupus- prone mice from histological lupus erythematosus-like skin inflammation induced by ultraviolet light. Exp Dermatol. 2016;25(12):969-976
8.Ray A, Mordorski B, Landriscina A, Rosen J, Nosanchuk J, Friedman A. Bensal HP Attenuates the Inflammatory Response in Hair Shaving Associated Dermatitis. J Drugs Dermatol. 2016; 15(7):836-840.
9.Mordorski B, Friedman A, Han G. Rapidly Progressive Acute Pustular Secondary Cutaneous Anaplastic Large Cell Lymphoma. J Drugs Dermatol. 2016; 15(9):1132- 1135.
10.Lee T, Friedman A. Skin Barrier Health: Regulation and Repair of the Stratum Corneum and the Role of Over-the-Counter Skin Care. J Drugs Dermatol. 2016;15(9):1047-1051.
11.Mordorski B, Friedman AJ, Kircik LH. Bensal HP for Second Intention Healing Following Mohs Micrographic Surgery or Shave Skin Biopsy: An Open-label Pilot Study. J Drugs Dermatol. 2016;15(10):1197-1202.
12.Schwartz J and Friedman A. Exogenous Factors in Skin Barrier Repair J Drugs Dermatol. 2016;15(11):1289-1294.
13.Yadgar R and Friedman A. Efficacy of a Skin Condition-Adapted Solution for Xerosis and Itch Relief Associated With Aging. J Drugs Dermatol. 2016;15(suppl 11):s91-94.
14.Idelchik MPS, Neu-Baker NM, Chandrasekaran A, Friedman AJ, Frame MD, Brenner SA. Relative Quantitation of Metal oxide nanoparticles in a cutaneous exposure model using enhanced darkfield microscopy and hyperspectral mapping. NanoImpact. 2016; 3-4: 12-21.
15.Martinez L, Mihu M, Cabral V, Pattabhi R, Tar M, Davies K, Friedman A, and Nosanchuk J. Sustained Nitric Oxide-Releasing Nanoparticles Interfere with Methicillin-Resistant Staphylococcus aureus Adhesion and Biofilm Formation in a Rat Central Venous Catheter Model. Antimicrob Agents Chemother. 2016; 27;61(1). pii: e02020-16.
16.Sharma D, Lee T, Friedman A, Redbord K. Need For Improved Skin Cancer Surveillance in Pediatric Cancer Survivors. Am J Clin Dermatol 2016 doi:10.1007/s40257-016-0241-1.
17. Lymphedema-Related Angiogenic Tumors and Other Malignancies. Lee R, Saardi KM, Schwartz RA Clinics in Dermatology, Jan 2016
2015
1. DeLuca IJ, Patel VA, Pereira MR, Grossman ME. A new polyomavirus-related dermatosis in a pancreatic transplant patient. JAAD Case Reports, 2015. 1(6):S38-S40.
2. Patel VA, Parikh S, Mahindra P, Ratner D. Voriconazole induced multiple Squamous Cell Carcinomas in a Chronic Lymphocytic Leukemia patient. Dermatologic Surgery 2015 Jun;41(6):747-9.
3. DeSimone JA, Sodha P, Cozzio A, Dummer R, Guenova E. Recent advances in primary cutaneous T-cell lymphoma. Current Opinion in Oncology. 2015;27: 128-33.
4. Nguyen TA, Patel PS, Viola KV, Friedman AJ. Pseudofolliculitis Barbae in Females: A Clinical Perspective. Br J Dermatol. 2015;173(1):279-81.
5. Rosen J, Landriscina A, Kutner A, Adler B, Krauz A, Nosanchuk D, Friedman A. Silver Sulfadiazine Retards Wound Healing in Mice via Alterations in Cytokine Expression. J Invest. Dermatol. 2015;135(5):1459-62
6. Charafeddine RA, Makdisi J, Schairer D, O'Rourke BP, Diaz-Valencia JD, Chouake J, Kutner A, Krausz A, Adler B, Nacharaju P, Liang H, Mukherjee S, Friedman JM, Friedman A, Nosanchuk JD, Sharp DJ. Fidgetin-Like 2: A Microtubule-Based Regulator of Wound Healing. J Invest Dermatol. 2015;135(9):2309-18.
7. Adler B, Kraus AE, Landriscina A, Musaev T, Nosanchuk JD, Friedman AJ. Biafine topical emulsion accelerates excisional and burn wound healing in mice. Arch Dermatol Res. 2015;307(7):583-94.
8. Baltazar LM, Karusz AE, Souza AC, Adler B, Landriscina A, Musaev T, Nosanchuk JD, Friedman AJ. Trichophyton rubrum is inhibited by free and nanoparticle encapsulated curcumin by induction of nitrosative stress after photodynamic activation. PLoS ONE 10(3): e0120179. doi:10.1371/journal. pone.0120179.
9.Sanchez D and Friedman A. The Skin Microbiome: Is there a Role in the Pathogenesis of Atopic Dermatitis and Psoriasis? J Drugs Dermatol. 2015;14(2):127-130.
10.Baltazar L, Ray A, Santos D, Cisalpino P, Friedman A and Nosanchuk JD. Antimicrobial photodynamic therapy: an effective alternative approach to control fungal infections. Front. Microbiol. 2015; 6:202. doi:10.3389/fmicb.2015.00202.
11.Akhavan A, Murphy-Cotorian B, and Friedman A. Pediatric Dermatology Training During Residency: A Survey of the 2014 Graduating Residents. Pediatr Dermatol. 2015;32(3):327-32.
12.Doerner J, Wen J, Xia Y, Blecher Paz K, Schairer D, Wu L, Chalmers SA, Izmirly P,Michaelson JS, Burkly LC, Friedman A, and Putterman C.TWEAK/Fn14 Signaling Involvement in the Pathogenesis of Cutaneous Disease in the MRL/lpr Model of Spontaneous Lupus J Invest Dermatol 2015;135(8):1986-95
13.Yu Y, Champers J, Beynet D, Kim J, Friedman A. The Role of the Cutaneous Microbiome in Skin Cancer: Lessons Learned from the Gut. J Drugs Dermatol. 2015;14(5):461-465.
14.Stamell E, Cohen J, Friedman A. Before OR After: Is There a Connection Between the Use of Adjunctive Nonmelanoma Skin Cancer Treatments and Subsequent Invasive Tumors? J Drugs Dermatol. 2015;14(5):450-451.
15.Landriscina A, Rosen J, Friedman AJ. Biodegradable chitosan nanoparticles in drug delivery for infectious disease. Nanomedicine (Lond). 2015;10(10):1609-19.
16.Rosen J, Landriscina A, Adler B, Krausz A,Doerner J, Navati M, Gravekamp C, Nosanchuk J, Friedman A. Characterization and Assessment of Nanoencapsulated Sanguinarine Chloride as a Potential Treatment for Melanoma. J Drugs Dermatol. 2015;14(5):453-458.
17.Ruiz ES, Ingram A, Landriscina A, Tian J, Kirsner RS, Friedman A. Identifying an Education Gap in Wound Care Training in United States Dermatology. J Drugs Dermatol. 2015. 14(7):716-720.
18.Musaev T, Landriscina A, Rosen J, Friedman AJ. The Management of Burn Injuries by Dermatologist: A Single Center Pilot Study. J Drugs Dermatol. 2015. 14(7):721-724.
19.Landriscina A, Musaev T, Rosen J, Ray A, Nacharaju P, Nosanchuk JD, Friedman AJ. N-acetylcysteine S-nitrosothiol Nanoparticles Prevent Wound Expansion and Accelerate Wound Closure in a Murine Burn Model. J Drugs Dermatol. 2015. 4(7):726-732.
20.Friedman A. Wound healing. J Drugs Dermatol. 2015; 14(7):658
21.Landriscina A, Rosen J, Friedman AJ. J Drugs Dermatol. Systematic Approach to Wound Dressings. 2015; 14(7):740-744.
22.Landriscina A, Rosen J, Friedman AJ. Nanotechnology, Inflammation and the Skin Barrier: Innovative Approaches for Skin Health and Cosmesis. Cosmetics 2015; 2: 177-186.
23.Friedman JM and Friedman AJ. Development and therapeutic applications of nitric oxide-releasing materials. Future Science OA. 2015; 1(1): DOI 10.4155/fso.15.50.
24.Adler B and Friedman A. Nitric oxide therapy for dermatologic disease Future Science OA. 2015; 1(1), DOI 10.4155/fso.15.37.
25.Krausz A and Friedman A. Nitric oxide as a surgical adjuvant Future Science OA. 2015; 1(1), DOI 10.4155/fso.15.56
26.Liang H, Nacharaju P, Friedman A, Friedman J. Nitric Oxide generating/releasing materials. Future Science OA. 2015; 1(1), DOI 10.4155/fso.15.54
27.Friedman A, Mordorski B, Kircik L. The Role of Topical Dapsone in the Treatment of Acne Vulgaris. Clin Aesthet Dermatol. 2015;8(11 Suppl):S1–S6.
28.Landriscina A, Rosen J, Blecher-Paz K, Long L, Ghannoum M, Nosanchuk J, Friedman AJ. Nitric oxide-releasing nanoparticles as a treatment for cutaneous dermatophyte infections. Sci Lett 2015, 4: 193
29.Landriscina A, Rosen J, Albanese J, Amin B, Friedman A. Identifying New Biologic Targets in Atopic Dermatitis: A Retrospective Histologic Analysis. J Am Acad Dermatol. 2015;73(3):521-3.
30.Qin M, Landriscina A, Rosen J, Wei G, Kao S, Olcott W, Agak GW, Paz KB, Bonventre J, Clendaniel A, Harper S, Adler B, Krausz A, Friedman J, Nosanchuk J, Kim J, Friedman AJ. Nitric Oxide Releasing Nanoparticles Prevent Propionibacterium acnes Induced Inflammation by both Clearing the Organism and Inhibiting Microbial Stimulation of the Innate Immune Response. J Invest Dermatol. 2015;135(11):2723-31.
31.Rosen J, Landriscina A, Ray A, Tesfa L, Nosanchuk JD, Friedman AJ. Bensal HP Treatment for Burn and Excision Wounds: An In-Vivo Assessment of Wound Healing Efficacy and Immunological Impact. J Drugs Dermatol. 2015 1;14(11):1322-1326.
32. Uremic Frost: A Harbinger of Impending Renal Failure. Saardi KM, Schwartz RA International Journal of Dermatology, Oct 2015
2014
1. Parikh S, Patel VA, Ratner D. Advances in the management of cutaneous squamous cell carcinaoma. F1000 Prime Rep. 2014 Aug 1;6:70.
2. Konda S, Patel VA, O'Bryan KW, Ratner D. Fibrohistiocytic Tumors in a Lung Transplant Patient Taking Oral Capecitabine for Nonmelanoma Skin Cancer Chemoprevention. Dermatologic Surgery 2014 Jul;40(7):807-10.
3. Sanchez, D, Schairer, D, Tuckman-Vernon, C, Chouake, C, Kutner, A, Makdisi J, Friedman, J, Nosanchuk J, Friedman, A. Amphotericin B Releasing Nanoparticle Topical Treatment of Candida in the Setting of a Burn Wound. Nanomedicine. 2014;10(1):269-77.
4. Chouake, J, Krausz, S, Adler, B, Cohen, H, Nosanchuk, J, Friedman, A. Management of Cutaneous Abscesses by Dermatologists. J Drugs Dermatol. 2014. 13(2). 119-125.
5. Cyrulnik, A, Dawkins, M, Smallberger G, Young, S, Mann, R, Jacobson, M, Friedman, A. Kaposiform Hemangioendothelioma with Kasabach-Merritt Syndrome Mistaken for Child Abuse in an Infant. Cutis. 2014;93(3):E17-E20.
6. Blecher, K, Cyrulnik, A, Amin, B, Mann, R, Krishnamurthy, K, Friedman, A. Multicentric Reticulohistiocytosis: Contrasting Presentations in Two Hispanic Patients. Cutis. 2014 93(5):243-6.
7. Adler, B, Krausz, A, and Friedman A. Acinetobacter baumannii as a mutli-drug resistant emerging skin and soft tissue pathogen: Parallels to methicillin-resistant Staphylococcus aureus. JAMA Dermatol. 2014;150(8):905-6.
8. Tar M, Cabrales P, Navati M, Adler B, Nacharaju P, Friedman A, Friedman J, Davies K. Topically applied NO-releasing nanoparticles can increase intracorporal pressure and elicit spontaneous erections in a rat model of radical prostatectomy. J Sex Med. 2014;11(12):2903-14
9. Adler, BL and Friedman, AJ. WHO's Who in Tropical Diseases. J Drugs Dermatol. 2014 1;13(2):210-216.
10. Krausz A, Friedman AJ. Antimicrobial Photodynamic Therapy: Applications Beyond Skin Cancer. J Drugs Dermatol. 2014;13(5):624-629.
11. Krausz A, Gunner H, Friedman AJ. The Basic Science of Natural Ingredients. J Drugs Dermatol. 2014;13(8):937-943.
12. Rosen J, Landriscina A, Friedman A. Principles and Approaches to Optimizing Therapy with Unique Vehicles. J Drugs Dermatol. 2014; 13(2): 1431-1436.
13. Rosen J and Friedman A. Inflammatory Acne: New Updates in Pathophysiology and Treatment. Cutis. 2014 ;94(6):266-267.
14. Adler BA, Krausz AE, Tian J, Nosanchuk JD, Kirsner R, Friedman AJ. Modifiable Lifestyle Factors in Psoriasis: Screening and Counseling Practices Among Dermatologists and Dermatology Residents in Academic Institutions. J Am Acad Dermatol. 2014; 71(5): 1028-1029.
15. Landriscina A, Musaev T, Friedman A. A Surprising Case of Mycobacterium avium Complex Skin Infection in an Immunocompetent Patient. J Drugs Dermatol. 2014;13(12):1491-1493
24. Uremic Frost: A Harbinger of Impending Renal Failure. Saardi KM, Schwartz RA International Journal of Dermatology, Oct 2015
2013
1. Patel VA, Ratner D. Targeted Molecular Therapies in Cutaneous Oncology: Ammunition Not Without Some Backfire. Cutis. 2013 Feb;91(2):61-2.
2. Weitz N, Patel VA, Tlougan B, Morel K, Garzon M, Lauren C. Metastatic Cutaneous Involvement of Granulomatous Colitis in Hermansky-Pudlak Syndrome. Pediatr Dermatol. 2013;30(6):278-80.
3. Friedman, AJ, Phan, J, Schairer,D, Champer, J, Qin, M , Pirouz, A, Blecher, K, Oren,A, Modlin, RL, and Kim,J. Antimicrobial and anti-inflammatory activity of chitosan-alginate nanoparticles: a novel targeted therapy for cutaneous pathogens. J Invest. Dermatol. 2013;133(5):1231-9.
4. Kutner, A and Friedman, A. Current Trends in Topical Antimicrobials. J Drugs Dermatol. 2013; 12(1): 122-126.
5. Makdisi, J and Friedman, A. Bacterial Skin and Soft Tissue Infections: A Review for the Dermatologist. J Drugs Dermatol. 2013; 12(3): 369-375.
6. Jariwala S, Benson A, Patel P, Friedman A, Broadway K. An Unusual Association between Sweet's Syndrome and Metastatic Papillary Follicular Thyroid Carcinoma. Ann Dermatol. 2013;25(1):84-7.
7. Makdisi, J, Amin, B, Friedman, A. Pityriasis rosea-like Drug Reaction to Asenapine. J Drugs Dermatol. 2013;12(9):1050-1051.
8. Schairer, D, Chouake, C, Kutner, A, Makdisi J, Nosanchuk J, Friedman, A. Evaluation of the antibiotic properties of Glutathione. J Drugs Dermatol. 2013; 12(11): 1272-1277.
9. Kutner, A and Friedman A. Use of Nitric Oxide Nanoparticles for the Treatment of Skin and Soft Tissue Infections. WIREs Nanomed Nanobiotechnol 2013. doi: 10.1002/wnan.1230
10. Kutner, A, and Friedman, A. Hair Loss in the Dermatology Office: An Update on Alopecia Areata. J Drugs Dermatol.2013; 12(5): 588-593.
11. Makdisi, J and Friedman, A. Myocosis Fungoides-An Update on a Non-Mycotic Disease. J Drugs Dermatol. 2013; 12(7): 825-831.
12. Pelgrift, R and Friedman, A. Topical Hypochlorous Acid as a Potential Treatment of Pruritus. Curr Dermatol Rep. 2013 2:181–190.
13. Pelgrift, R, and Friedman, A. Nanotechnology as a therapeutic tool to combat microbial resistance. Adv Drug Deliv Rev. 2013; 65(13-14):1803-15.
14. Adler, BL and Friedman, AJ. Safety & efficacy of agents used for home mole removal and skin cancer treatment in the internet age, and analysis of cases. J Drugs Dermatol. 2013; 12(9):1058-63.
15. Kutner, A, and Friedman, A. Nitric oxide nanoparticles for wound healing: future directions to overcome challenges. Expert Review of Dermatology. 2013; 8(5): 451-461.
16. Nguyen, T and Friedman, A. Curcumin: A Novel Treatment for Skin-related Disorders. J Drugs Dermatol. 2013; 12(10): 1131 1137.
17. Krausz, A and Friedman, A. Cutaneous Hyperandrogenism: Role of AntiandrogenTherapy in Acne, Hirsutism, and Androgenetic Alopecia. J Drugs Dermatol. 2013; 1297-1301.
18.Clark C, Silverberg JI, Alexis AF. A retrospective chart review to assess the safety of non-ablative fractional photothermolysis in Fitzpatrick skin types IV-VI. Journal of Drugs in Dermatology. 2013 Apr;12(4):428-31.
19. Silverberg JI, Simpson EL, Durkin HG, Joks R. Prevalence of allergic disease is lower in foreign-born American children, but increases with prolonged US residence. JAMA Pediatrics. 2013 Jun; 167(6): 554-60.
20. Silverberg JI and Silverberg NB. Quality of Life Impairment in Children and Adolescents with Vitiligo. Pediatric Dermatology. 2014 May-Jun;31(3):309-18. 620. Silverberg JI and Silverberg NB. Clinical Features of Vitiligo Associated with Comorbid Autoimmune Disease: A prospective survey. Journal of the American Academy of Dermatology. 2013 Nov. 69(5): 824-826.
21. Silverberg JI and Silverberg NB. Association between vitiligo and atopic disorders: A pilot study. JAMA Dermatology. 2013 Aug 1;149(8):963-86
22. Silverberg JI and Silverberg NB. Association Between Vitiligo Extent and Distribution on Quality of Life. JAMA Dermatology. Feb 2013. 149(2): 159-164.
23. Smith-Norowitz TA, Silverberg JI, Kusonruksa M, Weaver D, Ginsburg D, Norowitz KB, Durkin HG, Hammerschlag MR, Bluth MH, Kohlhoff SA. Asthmatic Children have Increased Specific Anti-Mycoplasma pneumoniae IgM but not IgG or IgE- Values Independent of History of Respiratory Tract Infection. Pediatric Infectious Disease Journal. 2013 Jun; 32(6):599-603.
2012
1. Ng E, Patel VA, Engler D, Grossman M. Chronic Lymphocytic Leukemia Associated Leukemia Cutis Presenting as Acne Rosacea. Leuk Lymphoma. 2012 Nov;53(11):2304-6.
2. Schairer, D, Martinez, L, Blecher, K, Chouake, J, Nacharaju, P Gialanella, P, Friedman J, Nosanchuk, J, Friedman, A. Nitric Oxide Nanoparticles: Pre-clinical Utility as a Therapeutic for Intramuscular Abscesses. Virulence 2012; 3(1):1-6.
3. Blecher, K Martinez, LR, Tuckman-Vernon, C, Nacharaju, P, Schairer, D, Chouake, J, Friedman, JM, Alfieri, A, Guha, C Nosanchuk, JD, Friedman, A. Nitric oxide- releasing nanoparticles accelerate wound healing in NOD-SCID mice. Nanomedicine. 2012;8(8):1364-71.
4. Marcherla, C, Sanchez, DA, Ahmadi, M, Vellozi, EM, Friedman, AJ, Nosanchuk, JD, Martinez, LR. Nitric Oxide Releasing Nanoparticles for the Treatment of Candida albicans Burn Infections. Front. Microbio. 2012;3:193. [Epub 2012 Jun 8.]
5. Tuckman-Vernon, C, Maier, KE, Chouake, J, Friedman, A, Cabrales, P, Friedman, JM, Nacharaju, P. A Nanoparticle Delivery Vehicle for S-nitroso-N-acetyl cysteine: Sustained Vascular Response. Nitric Oxide. 2012 Jun 15. [Epub ahead of print]
6. Chouake, J, Schairer, D, Kutner, A, Sanchez, D, Makdisi, J, Blecher-Paz, K, Nacharaju, P, Tuckman-vernon, C, Gialanella, P, Friedman, JM, Nosanchuk, JD, Friedman, A. Nitrosoglutathione Generating Nitric Oxide Nanoparticles as an Improved Strategy for Combating Pseudomonas aeruginosa – Infected Wounds. J Drugs Dermatol. 2012; 11(12):1471-1477.
7. Chouake, J and Friedman, A. Novel Therapies for the Treatment of Metastatic Melanoma. J Drugs Dermatol. 2012; 11(2): 271 273.
8. Schairer, D, Schairer, L, Friedman A. Psychology and Psychiatry in the Dermatologist’s Office: An Approach to Delusions of Parasitosis. J Drugs Dermatol. 2012; 11(4): 543-545.
9. Schairer, D, Chouake, J, Nosanchuk, JD, Friedman, A. The Potential of Nitric Oxide Releasing Therapies as Antimicrobial Agents. Virulence. 2012; 3(3): 1-9.
10. Chouake, J and Friedman A. Herbal Medicine in Dermatology: Does Natural = Safe? J Drugs Dermatol. 2012; 11(6): 774-776.
11. Sanchez, DA, Nosanchuk, JD, Friedman, A. The Purview of Nitric Oxide Nanoparticles in the Treatment of Infection and Wound Healing. Nanomedicine. 2012; 7(7): 1-4.
12. Blecher-Paz, K and Friedman A. Nanotechnology and the Diagnosis of Dermatological Infectious Diseases. J Drugs Dermatol. 2012; 11(7): 846- 851.
13. Chouake, J and Friedman A. The Outer Aspect of our Inner Anxiety: The Skinny on Stress. J Drugs Dermatol. 2012; 11(7): 883-885.
14. Kutner, A , Makdisi, J, and Friedman, A. Radiation Dermatitis: Current Perspectives and Future Directions . J Drugs Dermatol. 2012; 11(10): 1127-1131.
15. Makdisi, J, Kutner, A, and Friedman, A. The Role of RNA interference in Dermatology: Current Perspectives and Future Directions. J Drugs Dermatol. 2012; 11(11): 1373-1377.
16. Silverberg JI, Kleiman E, Silverberg NB, Durkin HG, Joks R, Smith-Norowitz TA. Varicella Zoster Virus Infection in Childhood is Associated with Persistent Decreases of Allergic Sensitization and Serum Immunoglobulin E Levels, and Numbers of Lymphocytes, Monocytes, and Basophils. Pediatric Allergy and Immunology. Feb 2012: 50-58.
17. Fitzpatrick S, Joks R, Silverberg JI. Obesity and Super Obesity Are Associated With Increased Asthma, Asthma Severity, and Severe Exacerbations in Inner City Adults. Clinical and Experimental Allergy. May 2012. 42(5): 747-759.
18.Silverberg JI and Silverberg NB. Adjunctive Trichloracetic Acid Therapy Enhances Squaric Acid Response For Verruca Vulgaris. Journal of Drugs in Dermatology. Oct 2012. 11(10): 1228-1231.
19. Silverberg JI, Votava HJ and Smith BL. Antiphospholipid Antibody Syndrome Secondary to Trimethoprim/Sulfamethoxazole. Journal of Drugs in Dermatology. Sep 2012. 11(9): 1117-1118.
20 Silverberg JI. A summary of atopic dermatitis research presented at the 2012 Society of Investigative Dermatology Annual Meeting. National Eczema Association Newsletter. June 2012.
21. Silverberg JI/ Wu S, Joks R, Durkin HG, Smith-Norowitz TA. Green Tea (Camelia Sinensis) Mediated Suppression of IgE Production by Peripheral Blood Mononuclear Cells of Allergic Asthmatic Humans. Scandinavian Journal of Immunology. 2012 Sep;76(3):306- 10.
22. Silverberg JI, Patel M, Brody N, Jagdeo J. Caffeine Protects Human Skin Fibroblasts From Acute Reactive Oxygen Species Induced Necrosis. Journal of Drugs in Dermatology. Nov 2012. 11(11): 1342–1346.
23. Lee-Wong M, Chou V, Silverberg JI. A study of IgE sensitization and skin response to histamine in Asian-Pacific American Adults. Allergy & Asthma Proceedings. Jul-Aug 2012. 33(4): 341-347.
24. Silverberg JI, Silverberg NB. False Highlighting with Wood’s Lamp. Pediatric Dermatology. 2012 Jul 2. doi: 10.1111/j.1525-1470.2012.01787.x. [Epub ahead of print].
25. Bhanusali DG, Coley MK, Silverberg JI, Alexis AF, Silverberg NB. Treatment Outcomes for Tinea Capitis in a Skin of Color Population. Journal of Drugs in Dermatology. July 2012. 11(7): 852-856.
26. Silverberg JI, Silverberg NB, Lee-Wong M. Association Between Atopic Dermatitis and Obesity in Adulthood. British Journal of Dermatology. March 2012. 166(3): 498-504.
27. Silverberg JI, Rodenas M, Sinert R, Joks R. Emergency department treatment of adults with acute asthma exacerbations: Effect on exhaled nitric oxide levels. Allergy & Asthma Proceedings. 2012. 33(6): 514-518.
2011
1. Evidence for Reduced Experience-Dependent Dendritic Spine Plasticity in the Aging Prefrontal Cortex Bloss EB, Janssen WG, Ohm DT, Yuk FJ, Wadsworth S, Saardi KM, McEwen BS, Morrison JH The Journal of Neuroscience, May 2011
2. Tintle S, Patel VA, Ruskin A, Halasz C. Azacitidine: a new medication associated with Sweet syndrome. Journal of American Academy of Dermatology 2011 May;64(5):e77-9.
3. Blecher K and Friedman AJ. Wound Healing: From Basic Science to Clinical Practice and Beyond. J Drugs Dermatol. 2011; 10(4): 427-433.
4. Blecher K and Friedman AJ. A Biopsy Diagnosis? Clinical Clues and Patterns to Help Distinguish Cutaneous Metastases. Part I of II. J Drugs Dermatol. 2011; 10(6): 678-682.
5. Blecher K and Friedman AJ. A Biopsy Diagnosis? Clinical Clues and Patterns to Help Distinguish Cutaneous Metastases. Part II of II. J Drugs Dermatol. 2011; 10(8): 930-935.
6. Cabrales, P, Han, G, Nacharaju, P, Friedman, AJ, Friedman, JM. Reversal of Hemoglobin-Induced Vasoconstriction with Sustained Release of Nitric Oxide. Am J Physiol Heart Circ Physiol. 2011; 300(1):H49-56.
7. Nacharaju, P, Friedman, AJ, Friedman, JM, Cabrales, P. Exogenous Nitric Oxide Prevents Collapse during Hemorrhagic Shock. Resuscitation. 2011; 82(5):607-13.
8. Friedman, A, Jacobson, M, Mann, R. Extensive Ulcerated Pigmented Nodules. J Am Acad Dermatol.2011; 64(5): 994-996.
9. Friedman, A, Blecher, K, Sanchez, D, Tuckman-Vernon, C, Gialanella, P, Friedman, JM, Martinez, L, Nosanchuk, J. Susceptibility of Gram Positive and Negative Bacteria to Novel Nitric Oxide-Releasing Nanoparticle Technology. Virulence. 2011; 2(3). 217-21.
10. Friedman, A and Nasir A. Nanotechnology and dermatology education in the United States: Data from a pilot survey. J Drugs Dermatol. 2011: 10(09); 1037-1041.
11. Friedman, A, Blecher, K, Schairer, D, Tuckman-Vernon, C, Nacharaju, P, Sanchez, D, Gialanelll, P, Martinez, L, Friedman, J, and Nosanchuk, J. Improved Antimicrobial Efficacy with Nitric Oxide Releasing Nanoparticle Generated S-Nitrosoglutathione. Nitric Oxide. 2011; 25: 381-386.
12. Blecher, K, Nasir, A, Friedman, A. The Growing Role of Nanotechnology in Combating infectious Disease. Virulence. 2011; 2(5): 395-401.
13. Friedman, A, and Cohen S. Program Spotlight: The Unified Division of Dermatology of the Albert Einstein College of Medicine. J Drugs Dermatol. 2011; 10(10): 1122-1123.
14. Lipoff, J and Friedman, A. Sound-alike and Look-alike Terms in Dermatology. J Drugs Dermatol. 2011; 10(10): 1196-1198.
15. Schairer, D and Friedman, A. Manifestations and Treatment of Cutaneous Lupus Erythematosus (Part I of II). J Drugs Dermatol. 2011; 10(10): 1212-1214.
16. Nasir, A, Wang S, and Friedman A. The Emerging Role of Nanotechnology in Sunprotection: An Update. Expert Review Dermatol. 2011; 6(5): 437-439
17. Schairer, D and Friedman, A. Manifestations and Treatment of Cutaneous Lupus Erythematosus (Part II of II). J Drugs Dermatol. 2011; 10(12): 1474-1476.
18. Frisella PD, Silverberg J, Joks R, Frieri M. Transforming growth factor beta: a role in the upper airway and rhinosinusitis-Dermatophagoides pteronyssinus-induced apoptosis with pulmonary alveolar cells. Am J Rhinol Allergy. Jul-Aug 2011. 25(4):231-5.
19. Silverberg JI, Silverberg NB. Topical Tacrolimus is More Effective for Treatment of Vitiligo in Patients of Skin of Color. Journal of Drugs in Dermatology. May 2011. 10(5): 507-511.
20. Silverberg JI, Kleiman E, Lev Tov H, Silverberg NB, Durkin HG, Joks R, Smith- Norowitz TA. Association Between Obesity and Atopic Dermatitis in Childhood: A Case- Control Study. Journal of Allergy and Clinical Immunology. May 2011. 127(5): 1180-1186.
21. Coley MK, Bhanusali D, Silverberg JI, Alexis AF, Silverberg NB. 2010. Scalp Hyperkeratosis and Alopecia in Children of Color. Journal of Drugs in Dermatology. May 2011. 10(5): 507-511.
22. Silverberg JI, Silverberg NB. Serum Homocysteine As A biomarker of Vitiligo Vulgaris Severity: A Pilot Study. Journal of the American Academy of Dermatology. Feb 2011. 64(2): 445-447.
23.Silverberg JI. Role of Obesity in Childhood Atopic Dermatitis. Expert Reviews of Dermatology. Dec 2011. 6(6): 635-642.
24. Silverberg JI, Jagdeo J, Patel M, Siemenskaja J, Michl J, Siegel D and Brody N. 2011. Green Tea Polyphenols protect against necrosis in human skin fibroblasts. Journal of Drugs in Dermatology. Oct 2011. 10(10):1096-1101.
2010
1. Han, G, Tar, M, Dwarakka, K, Friedman, A, Melman, A, Friedman, JM, Davies, KP. Nanoparticles as a Novel Delivery Vehicle for Therapeutics Targeting Erectile Dysfunction. J Sexu Med. 2010; 7(1 Pt 1):224-33.
3. Park, K, and Friedman, A. Dermatologic Indicators of Eating Disorders. J Drugs Dermatol. 2010; 9(4): 412-417.
4. Fenske, N, Spencer J, and Friedman, A. Actinic Keratoses: Past, Present, and Future. J Drugs Dermatol. 2010; 9(5): s44-47.
5. Kircik, L and Friedman, A. Optimizing Acne Treatment with Unique Vehicles. J Drugs Dermatol. 2010; 9(5): s51-54.
6. Fried, R and Friedman, A. Psychosocial Sequelae Related to Acne: Looking Beyond the Physical. J Drugs Dermatol. 2010; 9(5): s48-50.
7. Taub, A and Friedman, A. Laser Lipolysis. J Drugs Dermatol. 2010; 9(5): s55-58.
8. Sachdev, M and Friedman, A. Cosmeceuticals in Day to Day Practice. J Drugs Dermatol. 2010; 9(5): s59-62.
9. Englander, L and Friedman, A. Iron Overload and Cutaneous Disease: An Emphasis on Clinicopathological Correlations. J Drug Dermatol. 2010; 9(6):719-722.
10. Englander, L and Friedman, A. Nitric Oxide Nanoparticle Technology: A Novel Antimicrobial Agent in the Context of Current Treatments for Skin and Soft Tissue Infections J Clin Aesth Dermatol. 2010; 3(6): 45-50.
11. Friedman, A. From Bench to Bedside: Science for Boards and Wards: The Epidermis. Skin and Aging. 2010: 18(3).
12. Friedman, A. From Bench to Bedside: Science for Boards and Wards: The Basement Membrane Zone. Skin and Aging. 2010: 18(5).
13. Doshi, D and Friedman, A. The New Melanoma Staging System: What the Clinician Should Know ... J Drugs Dermatol. 2010; 9(7): 1029-1032.
14. Cyrulnik, A and Friedman, A. Dermatology in Pregnancy: A Current Approach to the Pregnant Patient. J Drugs Dermatol. 2010; 9(10): 1297-1304.
15. Stevenson, M and Friedman A. Dermatologic Emergencies. J Drugs Dermatol. 2010; 9(12):1545-1549
16. Friedman, A, Abadi, M, Wu, Katherine, Fisher, M, Abadi, J. An Unusual Ulcer in and 8-year-old Girl. Dermatol Online J. 2010; 16(2): 6.
17. Martinez, LM, Mihu, MR, Tar, M, Cordero, RJB, Han, G, Friedman, A, Friedman, JM, Nosanchuk, JD. Anti-biofilm and Antifungal Efficacy of Chitosan against Candidal Biofilms Using in vivo Central Venous Catheter Model. J Infect Dis. 2010 1;201(9):1436-40.
18. Cabrales, P, Han, G, Roche C, Nacharaju, P, Friedman, A, Friedman, J. Sustained Release Nitric Oxide from Long Lived Circulation Nanoparticles. Free Rad Med. 2010; 15;49(4):530-8.
19. Nasir, A and Friedman, A. Nanotechnology and the Nanodermatology Society. J Drugs Dermatol. 2010; 9(7): 879-882.
20.Silverberg JI, Norowitz K, Kleiman E, Silverberg NB, Durkin HG, Joks R, Smith- Norowitz T. Association between Varicella Zoster Virus Infection and Atopic Dermatitis in Early and Late Childhood: A Case-Control Study. Journal of Allergy and Clinical Immunology. Aug 2010. 126(2): 300-305.
21. Silverberg JI, Silverberg A, Malka A, Silverberg NB. Vitiligo patients with low serum levels of 25(OH)-Vitamin D are at increased risk of developing other autoimmune diseases. Journal of the American Academy of Dermatology. June 2010. 62(6): 937-941.
22. Silverberg JI, Ginsburg D, Amassian V, Orman R, Durkin HG and Stewart M. Lymphocyte infiltration of neocortex and hippocampus after a single brief seizure in mice. Brain, Behavior and Immunity. 2010; 24(2): 263-272.
23. Silverberg JI/Hassanain E, Norowitz KB, Chice S, Bluth MH, Brody N, Joks R, Durkin HG and Smith-Norowitz TA.Green tea (Camelia Sinensis) suppresses B cell production of IgE without inducing apoptosis. Annals of Clinical & Laboratory Science. 2010; 40(2). 40:135-143.
24. Bowser C, Erstein DP, Silverberg JI, Nowakowski M, Joks R. Correlation of plasma complement split product levels with allergic respiratory disease activity and relation to allergen immunotherapy. Ann Allergy Asthma Immunol. 2010; 104:42-49.
